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Section A: General synthetic methods 
Chemical reagents, solvents and starting materials were purchased from Sigma Aldrich, Goss 
Scientific, Alfa Aesar and Fisher Scientific and were used without further purification. Proton 
and carbon magnetic resonance spectra were recorded at 400.04 MHz or 500.13 MHz for 1H 
NMR, at 100.59 MHz or 125.76 MHz for 13C NMR and at 376 MHz for 19F NMR, using 
CD3OD, (CD3)2SO and CDCl3, containing SiMe4 as an internal standard. Reactions were 
monitored by thin-layer chromatography (TLC) on silica gel 60Å (particle size 40-63 µm). 
Most mass spectrometric data were obtained by means of electrospray ionisation using a 
microTOF instrument from Bruker Daltonics (Bremen, Germany) and calibrated using 
sodium formate solution. Melting points were obtained using a heated stage microscope 
(Reichert-Jung). Experiments were conducted at ambient temperature, unless otherwise 
noted. Solutions in organic solvents were dried with MgSO4. Pd2dba3 refers to tris(dibenzyl-
ideneacetone)dipalladium, SPhos refers to 2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl, 




Section B: Experimental methods - chemical synthesis 
5-Amino-3-(3-methoxyphenyl)isoquinolin-1-one hydrobromide (12e). Compound 31e (31 
mg, 110 mol) was stirred with HBr in AcOH (33%, 1.1 mL) at 65°C for 5 h. Evaporation 
yielded 12e (29 mg, 73%) as a pale buff solid: mp 202-205C; 1H NMR (CD3OD)  3.89 (3 
H, s, Me), 6.13 (1 H, s, N-H), 6.95 (1 H, s, 4-H), 7.10 (1 H, dt, J = 8.2, 0.6 Hz, Ph 4-H), 7.35 
(2 H, m, Ph 2,6-H2), 7.46 (1 H, t, J = 7.9 Hz, Ph 5-H), 7.61 (1 H, t, J = 7.9 Hz, 7-H), 7.83 (1 
H, dd, J = 7.7, 1.0 Hz, 6-H), 8.42 (1 H, d, J = 8.1 Hz, 8-H); 13C NMR (CD3OD) (HSQC / 
HMBC)  56.14 (Me), 98.49 (4-C), 113.73 (Ph 2-C), 116.98 (Ph 4-C), 120.39 (Ph 6-C), 
127.56 (8a-C), 127.66 (4a-C), 127.82 (7-C), 128.96 (6-C), 129.47 (8-C), 131.60 (Ph 5-C), 
134.01 (5-C), 136.68 (Ph 1-C), 144.29 (3-C), 161.82 (Ph 3-C), 164.54 (1-C); MS m/z 
267.1115 (M + H)+ (C16H13N2O2 requires 267.1135). 
5-Amino-3-(2-trifluoromethylphenyl)isoquinolin-1-one hydrobromide (12g). Compound 
31g (22.4 mg, 70 mol) was stirred with HBr in AcOH (33%, 1.25 mL) at 65°C for 5 h. 
Evaporation yielded 12g (25.2 mg, 94%) as a buff solid: mp >230C; 1H NMR (CD3OD) 
6.65 (1 H, s, 4-H), 7.69 (4 H, m, 7-H + Ph 4,5,6-H3), 7.85 (1 H, d, J = 8.5 Hz, 6-H), 7.88 (1 
H, d, J = 8.0 Hz, Ph 3-H), 8.45 (1 H, d, J = 8.0 Hz, 8-H); 13C NMR (CDCl3) (HSQC / 
HMBC)100.84 (4-C), 125.24 (q, J = 271.3 Hz, CF3), 127.40 (q, J = 5.3 Hz, Ph 1-C), 
127.56 (q, J = 4.8 Hz, Ph 3-C), 128.21 (7-C), 128.94 (6-C), 129.36 (8-C), 131.44 (Ph 6-C), 
130.10 (q, J = 30.6 Hz, Ph 2-C), 132.95 (5-C), 133.23 (Ph 4-C), 133.50 (Ph 5-C), 141.90 (3-
C), 163.54 (1-C); 19F NMR (CD3OD) -59.36 (s, CF3); MS m/z 305.0872 (M + H)+ 
(C16H12F3N2O requires 305.0904).  
5-Amino-3-(3-trifluoromethylphenyl)isoquinolin-1-one hydrobromide (12h). Compound 
31h (70.5 mg, 220 mol) was stirred with HBr in AcOH (33%, 3.75 mL) at 65°C for 7 h. 
Evaporation yielded 12h (82.4 mg, 97%) as a buff solid: mp >230C; 1H NMR ((CD3)2SO)  
7.05 (1 H, d, J = 7.7 Hz, 6-H), 7.16 (1 H, s, 4-H), 7.25 (1 H, t, J = 7.8 Hz, 7-H), 7.57 (1 H, d, 
J = 7.7 Hz, 8-H), 7.71 (1 H, t, J = 7.8 Hz, Ph 5-H), 7.77 (1 H, d, J = 7.9 Hz, Ph 4-H), 8.11 (1 
H, d, J = 8.0 Hz, Ph 6-H), 8.17 (1 H, s, Ph 2-H), 11.56 (1 H, br, NH); 13C NMR ((CD3)2SO) 
(HSQC / HMBC)  99.07 (4-C), 116.52 (8-C), 119.27 (6-C), 123.26 (q, J = 3.9 Hz, Ph 2-C), 
125.67 (q, J = 3.9 Hz, Ph 4-C), 126.19 (4a-C), 127.27 (7-C), 129.74 (q, J = 31.8 Hz, Ph 3-C), 
129.89 (Ph 5-C), 130.52 (Ph 6-C), 134.85 (5-C), 136.28 (Ph 1-C), 137.31 (3-C), 162.53 (1-
C); 19F NMR ((CD3)2SO)  -61.03 (s, CF3); MS m/z 303.0740 (M - H)- (C16H10F3N2O 
requires 303.0743).  
5-Amino-3-(4-trifluoromethylphenyl)isoquinolin-1-one hydrobromide (12i). Compound 
31i (85 mg, 270 mol) was stirred with HBr in AcOH (33%, 4.0 mL) at 65°C for 7 h. Evap-
oration yielded 12i (101 mg, 98%) as a buff solid: mp >230C (lit.1 mp 214–215C for free 
base); 1H NMR ((CD3)2SO)  7.17 (2 H, m, 4,6-H2), 7.32 (1 H, t, J = 7.5 Hz, 7-H), 7.67 (1 H, 
d, J = 7.5 Hz, 8-H), 7.88 (2 H, d, J = 8.0 Hz, Ph 3,5-H2), 8.04 (2 H, d, J = 8.0 Hz, Ph 2,6-H2), 
11.63 (1 H, br, NH); 13C NMR ((CD3)2SO) (HSQC / HMBC)  99.53 (4-C), 117.08 (8-C), 
118.87 (6-C), 124.11 (q, J = 270.6 Hz, CF3), 125.64 (q, J = 3.5 Hz, Ph 3,5-C2), 126.28 (4a-
C), 127.41 (7-C + Ph 2,6-C2), 129.20 (q, J = 31.8 Hz, Ph 4-C), 136.82 (Ph 1-C), 137.83 (3-
C), 139.92 (5-C), 162.46 (1-C); 19F NMR ((CD3)2SO)  -61.02 (s, CF3); MS m/z 303.0756 (M 
- H)- (C16H10F3N2O requires 303.0743). 
5-Amino-3-(4-fluorophenyl)isoquinolin-1-one hydrobromide (12j). Compound 31j (65 
mg, 24 mol) was stirred with HBr in AcOH (33%, 3.5 mL) at 65°C for 5 h. Evaporation 
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yielded 12j (80 mg, 98%) as a buff solid: mp >230C; 1H NMR (CD3OD) 6.99 (1 H, s, 4-
H), 7.34 (3 H, m, 8-H & Ph 3,5-H2), 7.39 (1 H, t, J = 8.5 Hz, 7-H), 7.45 (1 H, d, J = 8.5 Hz, 
6-H), 7.89 (2 H, m, Ph 2,6-H2), 11.71 (1 H, bs, NH); 13C NMR ((CD3)2SO) (HSQC / HMBC) 
98.62 (4-C), 115.48 (8-C), 115.68 (d, J =6.1 Hz, Ph 3,5-C2), 124.75 (Ph 1-C), 125.72 (3-C), 
126.66 (7-C), 128.99 (d, J = 17.2 Hz, Ph 2,6-C2), 130.11 (6-C), 137.96 (Ph 4-C), 141.34 (5-
C), 162.63 (1-C); 19F NMR ((CD3)2SO)  -112.47m, F); MS m/z 253.0756 (M – H)- 
(C15H10FN2O requires 253.0777).  
5-Amino-3-(2-chlorophenyl)isoquinolin-1-one hydrobromide (12k). Compound 31k (40.4 
mg, 140 mol) was stirred with HBr in AcOH (33%, 1.6 mL) at 65°C for 5 h. Evaporation 
yielded 12k (47.5 mg, 95%) as a buff solid: mp >230C; 1H NMR (CD3OD) 6.71 (1 H, s, 4-
H), 7.51 (2 H, m, Ph 4,5-H2), 7.60 (2 H, m, Ph 3,6-H2), 7.66 (1 H, t, J = 8.0 Hz, 7-H), 7.85 (1 
H, d, J = 7.5 Hz, 6-H), 8.45 (1 H, d, J = 8.5 Hz, 8-H); 13C NMR (CD3OD) (HSQC / 
HMBC)100.92 (4-C), 127.61 (4a-C), 128.14 (7-C), 128.55 (Ph 5-C), 128.83 (6-C), 129.34 
(8-C), 131.22 (Ph 3-C or Ph 6-C), 132.35 (Ph 6-C or Ph 3-C), 132.51 (Ph 4-C), 133.54 (5-C), 
134.17 (Ph 2-C), 134.98 (Ph 1-C), 142.26 (3-C), 163.87 (1-C); MS m/z 273.0597 (M + H) 
(C15H1237ClN2O requires 273.0609), 271.0623 (M + H)+ (C15H1235ClN2O requires 271.0638).  
5-Amino-3-(3-chlorophenyl)isoquinolin-1-one hydrobromide (12l). Compound 31l (38.5 
mg, 140 mol) was stirred with HBr in AcOH (33%, 1.5 mL) at 65°C for 5 h. Evaporation 
yielded 12l (46.1 mg, 97%) as a buff solid: mp >230C; 1H NMR (CD3OD)  6.93 (1 H, s, 4-
H), 7.55 (2 H, m, Ph 4,6-H2), 7.63 (1 H, t, J = 7.5 Hz, 7-H), 7.71 (1 H, m, Ph 5-H), 7.79 (1 H, 
d, J = 7.5 Hz, 6-H), 7.83 (1 H, s, Ph 2-H), 8.41 (1 H, d, J = 8.0 Hz, 8-H); 13C NMR (CD3OD) 
(HSQC / HMBC)  98.93 (4-C), 126.52 (Ph 5-C),128.09 (7-C), 128.17 (Ph 2-C), 128.47 (6-
C), 128.93 (8-C), 131.16 (Ph 4-C or Ph 6-C), 131.84 (Ph 6-C or Ph 4-C), 133.56 (5-C), 
136.19 (Ph 1-C), 137.24 (Ph 3-C), 142.63 (3-C), 166.31 (1-C); MS m/z 273.0584 (M + H)+ 
(C15H1237ClN2O requires 273.0609), 271.0616 (M + H)+ (C15H1235ClN2O requires 271.0638).  
5-Amino-3-(2,6-dichlorophenyl)isoquinolin-1-one hydrobromide (12n). Compound 31n 
(12.7 mg, 40 mol) was stirred with HBr in AcOH (33%, 1.0 mL) at 65°C for 5 h. Evaporat-
ion yielded 12n (9.0 mg, 58%) as an amber solid: mp 226-228C; 1H NMR (CD3OD)  6.73 
(1 H, s, 4-H), 7.56 (1 H, t, J = 6.6 Hz, Ph 4-H), 7.63 (2 H, d, J = 7.0 Hz, Ph 3,5-H2), 7.74 (1 
H, t, J = 7.9 Hz, 7-H), 7.91 (1 H, d, J = 7.5Hz, 6-H), 8.53 (1 H, d, J = 8.0 Hz, 8-H); 13C NMR 
(CD3OD) (HSQC / HMBC)  101.69 (4-C), 128.44 (7-C), 128.98 (6-C), 129.47 (8-C), 129.57 
(Ph 3,5-C2), 133.13 (Ph 4-C), 133.42 (5-C), 133.88 (Ph 1-C), 136.46 (Ph 2,6-C2), 139.26 (3-
C), 164.19 (1-C); MS m/z 327.0065 (M + Na)+ (C15H1035Cl2N2NaO requires 327.0068).  
5-Amino-3-(4-hydroxyphenyl)isoquinolin-1-one hydrobromide (12p). Compound 31p (55 
mg, 210 mol) was stirred with HBr in AcOH (33%, 2.5 mL) at 65°C for 16 h. Evaporation 
yielded 12p (68.5 mg, 98%) as a buff solid: mp >230C; 1H NMR ((CD3)2SO)  6.88 (3 H, 
m, 4-H + Ph 3,5-H2), 7.36 (2 H, m, 6,7-H2), 7.67 (2 H, d, J = 9.0 Hz, Ph 2,6-H2), 7.88 (1 H, d, 
J = 9.0 Hz, 8-H), 11.46 (1 H, br, NH); 13C NMR ((CD3)2SO) (HSQC / HMBC)  96.01 (4-C), 
115.55 (Ph 3,5-C2), 124.59 (7-C), 125.36 (6-C), 125.94 (8-C), 128.09 (Ph 2,6-C2), 139.99 (3-
C), 158.69 (Ph 4-C), 162.45 (1-C); MS m/z 253.0958 (M + H)+ (C15H13N2O2 requires 
253.0977).  
5-Amino-3-(2-phenylethyl)isoquinolin-1-one hydrobromide (12s). Compound 39 (40 mg, 
140 mol) was stirred with HBr in AcOH (33%, 2.0 mL) at 65°C for 16 h. Evaporation 
yielded 12s (35 mg, 70%) as a red-brown solid: mp >230C; 1H NMR (CD3OD)  2.95 (2 H, 
t, J = 7.0 Hz, ethyl 1-H2), 3.06 (2 H, t, J = 6.0 Hz, ethyl 2-H2), 6.48 (1 H, s, 4-H), 7.24 (5 H, 
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m, Ph-H5), 7.56 (1 H, t, J = 8.0 Hz, 7-H), 7.75 (1 H, dd, J = 8.0, 1.0 Hz, 6-H), 8.38 (1 H, d, J 
= 8.0 Hz, 8-H); 13C NMR (CD3OD) (HSQC / HMBC)  35.83 (ethyl 2-C), 36.51 (ethyl 1-C), 
97.82 (4-C), 126.76 (7-C), 127.07 (Ph 3-C), 127.48 (6-C), 129.36 (8-C), 129.43 (Ph 2,6-C2), 
129.62 (Ph 3,5-C2), 134.04 (5-C), 141.57 (Ph 1-C), 145.88 (3-C), 164.03 (1-C); MS m/z 
265.1320 (M + H)+ (C17H17N2O requires 265.1341).  
5-Amino-3-(4-aminocarbonylphenyl)isoquinolin-1-one hydrobromide (12u). Compound 
31r (14 mg, 50 mol) was stirred with HBr in AcOH (33%, 1.0 mL) at 65°C for 16 h. Evap-
oration yielded 12u (17.0 mg, 98%) as an amber solid: mp >230C; 1H NMR ((CD3)2SO)  
4.4 (3 H, m, +NH3), 7.14 (1 H, d, J = 7.8 Hz, 6-H), 7.17 (1 H, s, 4-H), 7.30 (1 H, t, J = 7.8 Hz, 
7-H), 7.46 (1 H, br, CONHH), 7.66 (1 H, d, J = 7.7 Hz, 8-H), 7.92 (2 H, d, J = 8.5 Hz, Ph 
2,6-H2), 7.99 (2 H, d, J = 8.5 Hz, Ph 3,5-H2), 8.08 (1 H, br, CONHH), 11.55 (1 H, bs, NH); 
13C NMR ((CD3)2SO) (HSQC / HMBC) 98.81 (4-C), 119.83 (8-C), 120.91 (6-C), 126.12 
(Ph 4-C), 126.30 (Ph 2,6-C2), 127.09 (7-C), 127.89 (Ph 3,5-C2), 134.48 (3-C), 136.30 (Ph 1-
C), 138.15 (5-C), 162.50 (1-C), 167.13 (CONH2); MS m/z 278.0947 (M - H)- (C16H12N3O2 
requires 278.0930).  
3-(4-(1,1-Dimethylethyl)phenyl)-5-methylisoquinolin-1-one (13c). BuLi (2.5 M in 
hexanes, 0.46 mL, 1.14 mmol) was added to dry Pri2NH (127.5 mg, 1.3 mmol) in dry THF 
(2.0 mL) at -78C and the mixture was stirred at -78C for 10 min. Compound 41 (200 mg, 
1.1 mmol) in dry THF (2.0 mL) was added and the mixture was stirred for 1 h at -78°C. 4-
(1,1-Dimethylethyl)benzonitrile (180 mg, 1.1 mmol) in dry THF (2.0 mL) was added and the 
mixture was stirred for 1 h at -78°C, then at 20C for 16 h. Water (1.0 mL) was added. The 
mixture was diluted with CH2Cl2, washed thrice with brine and dried. Evaporation and 
washing (EtOH) gave 13c (96.5 mg, 29%) as a white solid: mp 204-206°C; IR max 3295, 
1642 cm-1; 1H NMR ((CD3)2SO) (COSY)  1.33 (9 H, s, CMe3), 2.55 (3 H, s, 5-Me), 6.82 (1 
H, s, 4-H), 7.35 (1 H, t, J = 7.6 Hz, 7-H), 7.51 (2 H, d, J = 7.6 Hz, Ph 3,5-H2), 7.54 (1 H, d, J 
= 7.2 Hz, 6-H), 7.75 (2 H, d, J = 7.6 Hz, Ph 2,6-H2), 8.06 (1 H, d, J = 8.0 Hz, 8-H), 11.48 (1 
H, br, NH); 13C NMR ((CD3)2SO) (HSQC / HMBC)  18.75 (Me), 30.97 (CMe3), 34.44 
(CMe3), 99.60 (4-C), 124.56 (8-C), 124.86 (8a-C), 125.51 (Ph 3,5-C2), 125.72 (7-C), 126.56 
(Ph 2,6-C2), 131.44 (Ph 1-C), 133.15 (6-C), 133.60 (4a-C), 136.69 (5-C), 139.84 (3-C), 
151.87 (Ph 4-C), 162.97 (1-C); MS m/z 292.1686 (M + H)+ (C20H22NO requires 292.1703). 
3-(4-Methoxyphenyl)-5-methylisoquinolin-1-one (13d). BuLi (1.6 M in hexanes, 0.7 mL, 
1.1 mmol) was added to dry Pri2NH (141 mg, 1.4 mmol) in dry THF (2.0 mL) at -78C and 
the mixture was stirred at -78C for 10 min. Compound 41 (200 mg, 1.1 mmol) in dry THF 
(2.0 mL) was added and the mixture was stirred for 1 h at -78°C. 4-Methoxybenzonitrile (151 
mg, 1.1 mmol) in dry THF (2.0 mL) was added at -78°C and the mixture was stirred for 1 h 
at -78C, then at 20C for 16 h. Water (1.0 mL) was added. The mixture was diluted with 
CH2Cl2, washed thrice with brine and dried. Evaporation and washing (EtOH) gave 13d (48 
mg, 17%) as a white solid: mp 207-208°C; 1H NMR ((CD3)2SO) (COSY) 2.54 (1 H, s, 5-
Me), 3.82 (3 H, s, OMe), 6.77 (1 H, s, 4-H), 7.04 (2 H, d, J = 8.8 Hz, Ph 3,5-H2), 7.33 (1 H, t, 
J = 7.6 Hz, 7-H), 7.53 (1 H, d, J = 7.1 Hz, 6-H), 7.78 (2 H, d, J = 8.8 Hz, Ph 2,6-H2), 8.05 (1 
H, d, J = 8.0 Hz, 8-H), 11.45 (1 H, br, NH); 13C NMR ((CD3)2SO) (HSQC / HMBC) 18.81 
(5-Me), 55.34 (OMe), 98.87 (4-C), 114.15 (Ph 3,5-C2), 124.57 (8-C), 124.63 (8a-C), 125.51 
(7-C), 126.51 (Ph 1-C), 128.23 (Ph 2,6-C2), 133.15 (6-C), 133.49 (4a-C), 136.86 (5-C), 
139.70 (3-C), 160.14 (Ph 4-C), 163.02 (1-C); MS m/z 553.2099 (2 M + Na)+ (C34H30N2NaO4 
requires 553.2104); 288.0994 (M + Na)+ (C17H15NNaO2 requires 288.1000), 266.1179 (M + 
H)+ (C17H16NO2 requires 266.1181). 
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5-Methyl-3-(4-trifluoromethylphenyl)isoquinolin-1-one (13e). BuLi (1.6 M in hexanes, 1.1 
mL, 1.7 mmol) was added to dry Pri2NH (202 mg, 2.0 mmol) in dry THF (2.0 mL) at -78C 
and the mixture was stirred at -78C for 10 min. Compound 41 (300 mg, 1.7 mmol) in dry 
THF (2.0 mL) was added and the mixture was stirred for 1 h at -78°C. 4-Trifluoromethyl-
benzonitrile (289 mg, 1.7 mmol) in dry THF (2.0 mL) was added at -78 °C and the mixture 
was stirred for 1 h at -78C, then at 20C for 16 h. Water (1.0 mL) was added. The mixture 
was extracted with CH2Cl2. The extract was washed thrice with brine and dried. Evaporation 
and recrystallisation (EtOH) (25 mL) gave 13e (242 mg, 47%) as white crystals: mp 251-
252°C; 1H NMR ((CD3)2SO) (COSY)  2.56 (3 H, s, Me), 6.96 (1 H, s, 4-H), 7.40 (1 H, t, J = 
7.6 Hz, 7-H), 7.57 (1 H, d, J = 7.2 Hz, 6-H), 7.84 (2 H, d, J = 8.3 Hz, Ph 3,5-H2), 8.03 (2 H, 
d, J = 8.2 Hz, Ph 2,6-H2), 8.08 (1 H, d, J = 8.0 Hz, 8-H), 11.75 (1 H, br, N-H); 13C NMR 
((CD3)2SO)) (HSQC / HMBC)  18.77 (Me), 101.54 (4-C), 124.62 (8-C), 125.23 (q, J = 
295.9 Hz, CF3), 125.51 (8a-C), 125.56 (q, J = 3.6 Hz, Ph 3,5-C2), 126.54 (7-C), 129.25 (q, J 
= 31.6 Hz, Ph 4-C), 133.40 (6-C), 134.21 (4a-C), 136.29 (5-C), 138.10 (Ph 1-C), 138.36 (3-
C), 162.91 (1-C); 19F NMR ((CD3)2SO)) -61.08 (s, CF3); MS m/z 302.0808 (M - H)- 
(C17H11F3NO requires 308.0798). 
3-(2-Chlorophenyl)-5-methylisoquinolin-1-one (13f). BuLi (1.6 M in hexanes, 0.7 mL, 1.1 
mmol) was added to dry Pri2NH (141 mg, 1.4 mmol) in dry THF (2.0 mL) at -78C and the 
mixture was stirred at -78C for 10 min. Compound 41 (200 mg, 1.1 mmol) in dry THF (2.0 
mL) was added and the mixture was stirred for 1 h at -78°C. 2-Chlorobenzonitrile (155 mg, 
1.1 mmol) in dry THF (2.0 mL) was added at -78°C and the mixture was stirred for 1 h 
at -78C, then at 20C for 16 h. Water (1.0 mL) was added. The mixture was diluted with 
CH2Cl2. This mixture was washed thrice with brine and dried. The evaporation residue was 
washed (EtOH) to give 13f (4.9 mg, 2%) as a white solid: mp 178-180°C; 1H NMR 
((CD3)2SO) (COSY) 2.53 (3 H, s, Me), 6.58 (1 H, s, 4-H), 7.41 (1 H, t, J = 7.7 Hz, 7-H), 
7.47 (1 H, td, J = 7.5, 1.3 Hz, Ph 4-H), 7.51 (1 H, td, J = 7.5, 2.0 Hz, Ph 5-H), 7.59 (3 H, m, 
6-H + Ph 3,6-H2), 8.08 (1 H, d, J = 8.0 Hz, 8-H), 11.59 (1 H, br, NH); 13C NMR ((CD3)2SO) 
(HSQC / HMBC) 18.69 (Me), 102.43 (4-C), 124.61 (8-C), 125.33 (8a-C), 126.25 (7-C), 
127.34 (Ph 4-C), 129.70 (Ph 6-C), 130.84 (Ph 5-C), 131.56 (Ph 3-C), 132.29 (Ph 2-C), 
133.22 (6-C), 133.69 (4a-C), 134.24 (Ph 1-C), 136.31 (5-C), 138.15 (3-C), 162.24 (1-C); MS 
m/z 292.0514 (M + Na)+ (C16H1235ClNNaO requires 292.0505). 
3-(3-Chlorophenyl)-5-methylisoquinolin-1-one (13g). BuLi (1.6 M in hexanes, 0.7 mL, 1.1 
mmol) was added to dry Pri2NH (141 mg, 1.4 mmol) in dry THF (2.0 mL) at -78C and the 
mixture was stirred at -78C for 10 min. Compound 42 (200 mg, 1.1 mmol) in dry THF (2.0 
mL) was added and the mixture was stirred for 1 h at -78°C. 3-Chlorobenzonitrile (155 mg, 
1.1 mmol) in dry THF (2.0 mL) was added at -78°C and the mixture was stirred for 1 h 
at -78C, then at 20C for 16 h. Water (1.0 mL) was added. The mixture was diluted with 
CH2Cl2, washed thrice with brine and dried. Evaporation and recrystallisation (EtOH) gave 
13g (33 mg, 11%) as a white solid: mp 275-276°C; 1H NMR ((CD3)2SO) (COSY) 2.57 (3 
H, s, Me), 6.93 (1 H, s, 4-H), 7.39 (1 H, t, J = 7.6 Hz, 7-H), 7.52 (2 H, m, Ph 4,5-H2), 7.57 (1 
H, d, J = 7.2 Hz, 6-H), 7.80 (1 H, m, Ph 6-H), 7.93 (1 H, s, Ph 2-H), 8.07 (1 H, d, J = 8.0 Hz, 
8-H), 11.61 (1 H, br, NH); 13C NMR ((CD3)2SO) (HSQC / HMBC) 18.82 (Me), 100.92 (4-
C), 124.57 (8-C), 125.28 (8a-C), 125.64 (Ph 6-C), 126.32 (7-C), 126.74 (Ph 2-C), 129.01 (Ph 
4-C), 130.54 (Ph 5-C), 133.33 (6-C), 133.55 (Ph 1-C), 134.14 (4a-C), 136.20 (Ph 3-C), 
136.41 (5-C), 138.31 (3-C), 162.87 (1-C); MS m/z 292.0453 (M + Na)+ (C16H1235ClNNaO 
requires 292.0506), 270.0661 (M + H)+ (C16H1335ClNO requires 270.0686). 
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3-(4-Chlorophenyl)-5-methylisoquinolin-1-one (13h). BuLi (1.6 M in hexanes, 1.1 mL, 1.7 
mmol) was added to dry Pri2NH (202 mg, 2.0 mmol) in dry THF (2.0 mL) at -78C and the 
mixture was stirred at -78C for 10 min. Compound 41 (300 mg, 1.7 mmol) in dry THF (2.0 
mL) was added and the mixture was stirred for 1 h at -78°C. 4-Chlorobenzonitrile (233 mg, 
1.7 mmol) in dry THF (2.0 mL) was added at -78°C and the mixture was stirred for 1 h at -
78°C, then at 20°C for 2 h. Water (1.0 mL) was added, followed by CH2Cl2 (20 mL). The 
precipitate was collected by filtration to give 13h (456 mg, 99%) as a white solid: mp 
>360°C; 1H NMR ((CD3)2SO) (COSY)  2.61 (3 H, s, Me), 6.93 (1 H, s, 4-H), 7.44 (1 H, t, J 
= 7.6 Hz, 7-H), 7.61 (3 H, d, J = 8.5 Hz, 6-H + Ph 2,6-H3), 7.90 (2 H, d, J = 8.6 Hz, Ph 3,5-
H2), 8.12 (1 H, d, J = 7.8 Hz, 8-H), 11.70 (1 H, s, N-H); 13C NMR ((CD3)2SO)) (HSQC / 
HMBC)  18.80 (Me), 100.49 (4-C), 124.60 (8-C), 125.11 (8a-C), 126.19 (7-C), 128.73 (Ph 
2,6-C2), 128.78 (Ph 3,5-C2), 133.01 (4a-C), 133.34 (6-C), 133.96 (Ph 1,4-C2), 136.49 (5-C), 
138.67 (3-C), 162.95 (1-C); MS m/z 270 (M – H)-, 268.0533 (M – H)- (C16H1135ClNO 
requires 268.0535). 
3-(2,6-Dichlorophenyl)-5-methylisoquinolin-1-one (13i). BuLi (1.6 M in hexanes, 0.7 mL, 
1.1 mmol) was added to dry Pri2NH (141 mg, 1.4 mmol) in dry THF (2.0 mL) at -78C and 
the mixture was stirred at -78C for 10 min. Compound 41 (200 mg, 1.1 mmol) in dry THF 
(2.0 mL) was added and the mixture was stirred for 1 h at -78°C. 2,6-Dichlorobenzonitrile 
(194 mg, 1.1 mmol) in dry THF (2.0 mL) was added at -78°C and the mixture was stirred for 
1 h at -78C, then at 20C for 16 h. Water (1.0 mL) was added. The mixture was diluted with 
CH2Cl2, washed thrice with brine and dried. Evaporation and recrystallisation (EtOH) gave 
13i (35 mg, 10%) as a pale buff solid: mp 202-204°C; 1H NMR ((CD3)2SO) (COSY) 2.47 
(3 H, s, Me), 6.58 (1 H, s, 4-H), 7.43 (1 H, t, J = 7.6 Hz, 7-H), 7.55 (1 H, t, J = 7.2 Hz, Ph 4-
H), 7.58 (1 H, d, J = 7.3 Hz, 6-H), 7.59 (2 H, d, J = 7.6 Hz, Ph 3,5-H2), 8.09 (1 H, d, J = 7.9 
Hz, 8-H), 11.62 (1 H, br, NH); 13C NMR ((CD3)2SO) (HSQC / HMBC) 18.66 (Me), 102.81 
(4-C), 124.61 (8-C), 125.58 (8a-C), 126.45 (7-C), 128.28 (Ph 3,5-C2), 131.67 (Ph 4-C), 
133.19 (Ph 1-C), 133.29 (6-C), 133.75 (4a-C), 134.69 (Ph 2,6-C2), 135.20 (3-C), 136.24 (5-
C), 162.37 (1-C); MS m/z 326.0991 (M + Na)+ (C16H1135Cl2NNaO requires 326.0115), 
304.0286 ((M + H)+ (C16H1235Cl2NO requires 304.0296). 
3-(4-Bromophenyl)-5-methylisoquinolin-1-one (13j). BuLi (1.6 M in hexanes, 0.9 mL, 1.4 
mmol) was added to dry Pri2NH (162 mg, 1.6 mmol) in dry THF (2.0 mL) at -78C and the 
mixture was stirred at -78C for 10 min. Compound 41 (241 mg, 1.4 mmol) in dry THF (2.0 
mL) was added and the mixture was stirred for 1 h at -78°C. 4-Bromobenzonitrile (248 mg, 
1.4 mmol) in dry THF (2.0 mL) was added at -78°C and the mixture was stirred for 1 h 
at -78C, then at 20C for 16 h. Water (1.0 mL) was added. The mixture was diluted with 
CH2Cl2 (20 mL). The solid was collected by filtration and washed (EtOH) to give 13j (181 
mg, 42%) as a white solid: mp 278-279°C; 1H NMR ((CD3)2SO) (COSY) 2.55 (3 H, s, Me), 
6.88 (1 H, s, 4-H), 7.38 (1 H, t, J = 7.7 Hz, 7-H), 7.56 (1 H, d, J = 7.2 Hz, 6-H), 7.69 (2 H, d, 
J = 8.5 Hz, Ph 2,6-H2), 7.78 (2 H, d, J = 8.5 Hz, Ph 3,5-H2), 8.07 (1 H, d, J = 8.0 Hz, 8-H), 
11.59 (1 H, br, NH); 13C NMR ((CD3)2SO) (HSQC / HMBC) 18.81 (Me), 100.47 (4-
C),122.66 (Ph 4-C), 124.62 (8-C), 125.13 (8a-C), 126.20 (7-C), 129.03 (Ph 3,5-C2), 131.66 
(Ph 2,6-C2), 133.34 (6-C), 133.43 (Ph 1-C), 133.97 (4a-C), 136.51 (5-C), 138.81 (3-C), 
162.99 (1-C); MS m/z 335.9966 (M + Na)+ (C16H1279BrNNaO requires 336.0000) 
5-Methyl-3-(4-phenylethynylphenyl)isoquinolin-1-one (13k). BuLi (1.6 M in hexanes, 0.7 
mL, 1.1 mmol) was added to dry Pri2NH (141 mg, 1.4 mmol) in dry THF (2.0 mL) at -78C 
and the mixture was stirred at this temperature for 10 min. Compound 41 (230 mg, 1.1 mmol) 
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in dry THF (2.0 mL) was added and the mixture was stirred for 1 h at -78°C. Compound 43 
(194 mg, 1.1 mmol) in dry THF (2.0 mL) was added at -78°C and the mixture was stirred for 
1 h at -78°C, then at 20°C for 16 h. Water (1.0 mL) was added. The mixture was diluted with 
CH2Cl2. The solid was collected by filtration and washed (EtOH) to give 13k (117 mg, 31%) 
as a white solid: mp 285-287°C; 1H NMR ((CD3)2SO) (COSY) (2.57, s, Me), 6.94 (1 H, s, 
4-H), 7.39 (1 H, t, J = 7.6 Hz, 7-H), 7.45 (3 H, m, Ph 3,4,5-H3), 7.56 (1 H, d, J = 7.4 Hz, 6-
H), 7.59 (2 H, m, Ph 2,6-H2), 7.67 (2 H, d, J = 8.0 Hz, Ar 3,5-H2), 7.90 (2 H, d, J = 8.0 Hz, 
Ar 2,6-H2), 8.08 (1 H, d, J = 7.9 Hz, 8-H), 11.62 (1 H, br, NH); 13C NMR ((CD3)2SO) (HSQC 
/ HMBC) 18.82 (Me), 88.99 (ethyne 1-C), 90.86 (ethyne 2-C), 100.64 (4-C), 122.09 (Ph 1-
C), 122.92 (Ar 4-C), 124.61 (8-C), 125.18 (8a-C), 126.21 (7-C), 126.15 (Ar 2,6-C2), 128.84 
(Ph 3,5-C2), 129.03 (Ph 10-C), 131.47 (Ph 2,6-C2), 131.66 (Ar 3,5-C2), 133.29 (6-C), 134.03 
(4a-C), 134.17 (Ar 1-C), 136.50 (5-C), 139.00 (3-C), 163.00 (1-C); MS m/z 358.1218 (M + 
Na)+ (C24H17NNaO requires 358.1208), 336.1402 (M + H)+ (C24H18NO requires 336.1388). 
5-Methyl-3-(4-(piperidin-1-ylmethyl)phenyl)isoquinolin-1-one (13m). BuLi (1.6 M in 
hexanes, 0.7 mL, 1.1 mmol) was added to dry Pri2NH (142 mg, 1.4 mmol) in dry THF (2.0 
mL) at -78C and the mixture was stirred at -78C for 10 min. Compound 41 (200 mg, 1.1 
mmol) in dry THF (2.0 mL) was added and the mixture was stirred for 1 h at -78°C. 
Compound 45b (226 mg, 1.1 mmol) in dry THF (2.0 mL) was added and the mixture was 
stirred for 1 h at this temperature, then at room temperature for 16 h. Water (1.0 mL) was 
added. The mixture was diluted with CH2Cl2, washed thrice with saturated brine and dried. 
Evaporation and washing (EtOH) gave 13m (78 mg, 21%) as a white solid: mp 196-197°C; 
IR νmax 3440 (NH), 1644 (C=O); 1H NMR ((CD3)2SO)  1.40 (2 H, m, piperidine 4-H2), 1.50 
(4 H, m, piperidine 3,5-H4), 2.34 (4 H, m, piperidine 2,6-H4), 2.55 (3 H, s, Me), 3.47 (2 H, s, 
PhCH2), 6.84 (1 H, s, 4-H), 7.36 (1 H, t, J = 7.7 Hz, 7-H), 7.40 (2 H, d, J = 8.2 Hz, Ph 3,5-
H2), 7.54 (1 H, d, J = 7.1 Hz, 6-H), 7.76 (2 H, d, J = 8.2 Hz, Ph 2,6-H2), 8.06 (1 H, d, J = 7.9 
Hz, 8-H), 11.48 (1 H, bs, N-H); 13C NMR ((CD3)2SO) (HSQC / HMBC)  18.76 (Me), 23.96 
(piperidine 4), 25.55 (piperidine 3,5-C2), 53.91 (piperidine 2,6-C2), 62.37 (PhCH2), 99.73 (4-
C), 124.56 (8-C), 124.90 (8a-C), 125.79 (7-C), 126.61 (Ph 2,6-C2), 129.01 (Ph 3,5-C2), 
132.67 (Ph 1-C), 133.18 (6-C), 133.68 (4a-C), 136.66 (5-C), 139.78 (Ph 4-C), 140.06 (3-C), 
162.95 (1-C); MS m/z 665.3884 (2 M + H)+ (C44H49N4O2 requires 665.3855), 355.1805 (M + 
Na)+ (C22H24N2NaO requires 355.1786). 
5-Methyl-3-(4-(pyrrolidin-1-ylmethyl)phenyl)isoquinolin-1-one hydrochloride (13n). 
BuLi (2.5 M in hexanes, 0.46 mL, 1.14 mmol) was added to dry Pri2NH (127.5 mg, 1.3 
mmol) in dry THF (2.0 mL) at -78C and the mixture was stirred at -78C for 10 min. Com-
pound 41 (200 mg, 1.13 mmol) in dry THF (2.0 mL) was added and the mixture was stirred 
for 1 h at -78°C. Compound 45c (210.5 mg, 1.13 mmol) in dry THF (2.0 mL) was added and 
the mixture was stirred for 1 h at -78C, then at 20C for 16 h. Water (1.0 mL) was added. 
The mixture was diluted with CH2Cl2, washed thrice with brine and dried. Evaporation and 
washing (EtOH) gave 13n (32 mg, 9%) as a pale yellow solid: mp >360°C; IR max 3413, 
1640 cm-1; The solid was then treated for 16 h with aq. HCl (6.0 M, 2.0 mL). Evaporation 
and drying gave the HCl salt as a white solid: mp >360°C; 1H NMR ((CD3)2SO)  1.70 (4 H, 
m, pyrrolidine 3,4-H4), 2.44 (4 H, m, pyrrolidine 2,5-H4), 2.54 (3 H, s, Me), 3.61 (2 H, s, 
PhCH2), 6.83 (1 H, s, 4-H), 7.35 (1 H, t, J = 7.7 Hz, 7-H), 7.41 (2 H, d, J = 8.2 Hz, Ph 3,5-
H2), 7.54 (1 H, d, J = 7.2 Hz, 6-H), 7.76 (2 H, d, J = 8.2 Hz, Ph 2,6-H2), 8.05 (1 H, d, J = 7.9 
Hz, 8-H), 11.52 (1 H, br, NH); 13C NMR ((CD3)2SO) (HSQC / HMBC)  18.77 (Me), 23.12 
(pyrrolidine 3,4-C2), 53.50 (pyrrolidine 2,5-C2), 59.15 (PhCH2), 99.72 (4-C), 124.55 (8-C), 
124.92 (8a-C), 125.80 (7-C), 126.64 (Ph 2,6-C2), 128.71 (Ph 3,5-C2), 132.64 (Ph 1-C), 
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133.30 (6-C), 133.68 (4a-C), 136.81 (5-C), 139.86 (3-C), 140.96 (Ph 4-C), 163.24 (1-C); MS 
m/z 319.1788 (M + H)+ (C21H23N2O requires 319.1810).  
5-Methyl-3-(4-((4-methylpiperazin-1-yl)methyl)phenyl)isoquinolin-1-one dihydro-
chloride (13o). BuLi (2.5 M in hexanes, 0.46 mL, 1.14 mmol) was added to dry Pri2NH (128 
mg, 1.3 mmol) in dry THF (2.0 mL) at -78C and the mixture was stirred at -78C for 10 min. 
Compound 41 (200 mg, 1.13 mmol) in dry THF (2.0 mL) was added and the mixture was 
stirred for 1 h at -78°C. Compound 45d (243 mg, 1.13 mmol) in dry THF (2.0 mL) was 
added and the mixture was stirred for 1 h at -78°C, then at 20°C for 16 h. Water (1.0 mL) was 
added. The mixture was diluted with CH2Cl2, washed thrice with brine and dried. The evap-
oration residue was washed (EtOH) to give 13o (8 mg, 2%) as a white solid: mp >360°C. The 
solid was treated for 16 h with aq. HCl (6 M, 1.0 mL). Evaporation and drying gave the 
2.HCl salt: mp >360°C; IR max 3419, 1636 cm-1; 1H NMR ((CD3)2SO)  2.14 (3 H, s, NMe), 
2.35 (8 H, m, piperazine-H8), 2.54 (3 H, s, 5-Me), 3.49 (PhCH2), 6.83 (1 H, s, 4-H), 7.35 (1 
H, t, J = 7.7 Hz, 7-H), 7.39 (2 H, d, J = 8.2 Hz, Ph 3,5-H2), 7.54 (1 H, d, J = 7.2 Hz, 6-H), 
7.76 (2 H, d, J = 8.2 Hz, Ph 2,6-H2), 8.05 (1 H, d, J = 7.9 Hz, 8-H), 11.51 (1 H, br, N-H); 13C 
NMR ((CD3)2SO) (HSQC / HMBC)  18.76 (5-Me), 40.08 (NMe), 52.57 (piperazine 2,6-C2), 
54.70 (piperazine 3,5-C2), 61.57 (PhCH2), 99.75 (4-C), 124.56 (8-C), 124.92 (8a-C), 125.81 
(7-C), 126.65 (Ph 2,6-C2), 129.65 (Ph 3,5-C2), 132.79 (Ph 1-C), 133.18 (6-C), 133.69 (4a-C), 
136.65 (5-C), 139.67 (Ph 4-C), 139.75 (3-C), 162.94 (1-C); MS m/z 348.2076 (M + H)+ 
(C22H26N3O requires 348.2076). 
5-Methyl-3-(pyridin-4-yl)isoquinolin-1-one (13p). BuLi (1.6 M in hexanes, 0.7 mL, 1.1 
mmol) was added to dry Pri2NH (142 mg, 1.4 mmol) in dry THF (2.0 mL) at -78C and the 
mixture was stirred at -78C for 10 min. Compound 41 (200 mg, 1.1 mmol) in dry THF (2.0 
mL) was added and the mixture was stirred for 1 h at -78°C. 4-Cyanopyridine (118 mg, 1.1 
mmol) in dry THF (2.0 mL) was added and the mixture was stirred for 1 h at -78C, then at 
20C for 16 h. Water (1.0 mL) was added. The mixture was diluted with CH2Cl2, washed 
thrice with brine and dried. Evaporation and recrystallisation (EtOH) gave 13p (16.5 mg, 6%) 
as white crystals: mp 268-269°C; IR max 3450, 1654 cm-1; 1H NMR ((CD3)2SO) (COSY)  
2.59 (3 H, s, Me), 7.11 (1 H, s, 4-H), 7.44 (1 H, t, J = 7.7 Hz, 7-H), 7.60 (1 H, d, J = 7.2 Hz, 
6-H), 7.87 (2 H, d, J = 6.2 Hz, Ph 3,5-H2), 8.10 (1 H, d, J = 8.0 Hz, 8-H), 8.69 (2 H, d, J = 6.2 
Hz,, Ph 2,6-H2), 11.70 (1 H, br, NH); 13C NMR ((CD3)2SO) (HSQC / HMBC)  18.76 (Me), 
101.87 (4-C), 120.96 (pyridine 3,5-C2), 124.65 (8-C), 125.83 (8a-C), 126.91 (7-C), 133.49 (6-
C), 134.50 (4a-C), 136.06 (5-C), 137.06 (pyridine 4-C), 141.03 (3-C), 150.13 (pyridine 2,6-
C2), 162.85 (1-C); MS m/z 235.0864 (M - H)- (C15H11N2O requires 235.0871).  
3-(Benzo-1,3-dioxol-5-yl)-5-methylisoquinolin-1-one (13q). BuLi (1.6 M in hexanes, 0.70 
mL, 1.1 mmol) was added to dry Pri2NH (141 mg, 1.4 mmol) in dry THF (2.0 mL) at -78C 
and the mixture was stirred at -78C for 10 min. Compound 41 (200 mg, 1.1 mmol) in dry 
THF (2.0 mL) was added and the mixture was stirred for 1 h at -78°C. 5-Cyanobenzo-1,3-di-
oxole (166 mg, 1.1 mmol) in dry THF (2.0 mL) was added at -78°C and the mixture was 
stirred for 1 h at -78°C, then at 20°C for 16 h. Water (1.0 mL) was added. The mixture was 
diluted with CH2Cl2. The solid was collected by filtration, washed (EtOH) and dried to give 
13q (199 mg, 63%) as a white solid. mp >360°C; 1H NMR ((CD3)2SO) (COSY) 2.54 (3 H, 
s, Me), 6.10 (2 H, s, CH2), 6.78 (1 H, s, 4-H), 7.02 (1 H, d, J = 8.2 Hz, benzodioxole 6-H), 
7.33 (1 H, t, J = 7.7 Hz, 7-H), 7.34 (1 H, dd, J = 8.1, 1.8 Hz, benzodioxole 7-H), 7.43 (1 H, d, 
J = 1.8 Hz, benzodioxole 4-H), 7.52 (1 H, d, J = 7.2 Hz, 6-H), 8.04 (1 H, d, J = 8.0 Hz, 8-H), 
11.44 (1 H, br, NH); 13C NMR ((CD3)2SO) (HSQC / HMBC) 18.83 (Me), 99.37 (4-C), 
101.52 (CH2), 107.27 (benzodioxole 4-C), 108.46 (benzodioxole 7-C), 121.07 (benzodioxole 
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6-C), 124.56 (8-C), 124.72 (8a-C), 125.60 (7-C), 128.40 (benzodioxole 5-C), 133.12 (6-C), 
133.62 (4a-C), 136.80 (5-C), 139.77 (3-C), 147.71 (benzodioxole 7a-C), 148.17 (benzodi-
oxole 3a-C), 163.14 (1-C); MS m/z 278.0797 (M - H)- (C17H12NO3 requires 278.0817). 
5-Methyl-3-(thiophen-3-yl)isoquinolin-1-one (13r). BuLi (2.5 M in hexanes, 0.46 mL, 1.1 
mmol) was added to dry Pri2NH (127.5 mg, 1.3 mmol) in dry THF (2.0 mL) at -78C and the 
mixture was stirred at -78C for 10 min. Compound 41 (200 mg, 1.13 mmol) in dry THF (2.0 
mL) was added and the mixture was stirred for 1 h at -78°C. 3-Cyanothiophene (123 mg, 1.1 
mmol) in dry THF (2.0 mL) was added and the mixture was stirred for 1 h at -78°C, then at 
20°C for 16 h. Water (1.0 mL) was added. The mixture was diluted with CH2Cl2 and washed 
thrice with saturated brine. Drying, evaporation and washing (EtOH) gave 13r (17 mg, 6%) 
as a pale buff solid: mp >360°C; IR max 3448, 1647 cm-1; 1H NMR ((CD3)2SO) (COSY)  
2.56 (3 H, s, Me), 6.99 (1 H, s, 4-H), 7.34 (1 H, t, J = 7.6 Hz, 7-H), 7.54 (1 H, d, J = 7.1 Hz, 
6-H), 7.70 (1 H, m, thiophene 4-H), 7.78 (1 H, d, J = 4.6 Hz, thiophene 5-H), 8.04 (1 H, d, J 
= 8.0 Hz, 8-H), 8.28 (1 H, d, J = 1.5 Hz, thiophene 2-H), 11.47 (1 H, br, NH); 13C NMR 
((CD3)2SO) (HSQC / HMBC)  18.80 (Me), 99.09 (4-C), 123.46 (thiophene 2-C), 124.58 (8-
C), 124.95 (8a-C), 125.74 (7-C), 126.16 (thiophene 5-C), 127.27 (thiophene 4-C), 133.25 (6-
C), 133.73 (4a-C), 134.95 (thiophene 1-C), 135.37 (3-C), 136.72 (5-C), 162.80 (1-C); MS m/z 
264.0454 (M + Na)+ (C14H11NNaOS requires 264.0459). 
5-Fluoro-3-(4-methylphenyl)isoquinolin-1-one (14b). BuLi (1.6 M in hexanes, 0.7 mL, 1.1 
mmol) was added to dry Pri2NH (142 mg, 1.4 mmol) in dry THF (2.0 mL) at -78C and the 
mixture was stirred at -78C for 10 min. Compound 49 (200 mg, 1.1 mmol) in dry THF (2.0 
mL) was added and the mixture was stirred for 1 h at -78°C. 4-Methylbenzonitrile (129 mg, 
1.1 mmol) in dry THF (2.0 mL) was added and the mixture was stirred for 1 h at -78°C, then 
at 20°C for 16 h. Water (1.0 mL) was added. The mixture was diluted with CH2Cl2, washed 
thrice with brine and dried. Evaporation and recrystallisation (EtOH) gave 14b (50 mg, 18%) 
as white crystals: mp 232-233°C; IR max 3481, 1668, 1235 cm-1; 1H NMR ((CD3)2SO) 
(COSY)  2.37 (3 H, s, Me), 6.81 (1 H, s, 4-H), 7.30 (2 H, d, J = 8.0 Hz, Ph 3,5-H2), 7.48 (1 
H, m, 7-H), 7.58 (1 H, t, J = 8.1 Hz, 6-H), 7.71 (2 H, d, J = 8.0 Hz, Ph 2,6-H2), 8.03 (1 H, d, J 
= 8.0 Hz, 8-H), 11.70 (1 H, br, NH); 13C NMR ((CD3)2SO) (HSQC / HMBC)  20.83 (Me), 
94.19 (d, J = 5.1 Hz, 4-C), 117.57 (d, J = 19.5 Hz, 6-C), 122.77 (d, J = 3.3 Hz, 8-C), 126.46 
(d, J = 3.4 Hz, 8a-C); 126.59 (d, J = 7.6 Hz, 7-C), 126.79 (Ph 2,6-C2), 127.06 (d, J = 16.5 Hz, 
4a-C), 129.40 (Ph 3,5-H2), 130.74 (Ph 1-C), 139.38 (Ph 4-C), 141.40 (3-C), 157.26 (d, J = 
248.1 Hz, 5-C), 161.81 (d, J = 2.8 Hz, 1-C); 19F NMR ((CD3)2SO)  -122.08 (dd, J = 10.4, 
5.2 Hz, F); MS m/z 252.0807 (M - H)- (C16H11FNO requires 252.0824). 
5-Fluoro-3-(4-methoxyphenyl)isoquinolin-1-one (14c). BuLi (1.6 M in hexanes, 0.7 mL, 
1.1 mmol) was added to dry Pri2NH (131 mg, 1.3 mmol) in dry THF (2.0 mL) at -78C and 
the mixture was stirred at -78C for 10 min. Compound 49 (200 mg, 1.1 mmol) in dry THF 
(2.0 mL) was added and the mixture was stirred for 1 h at -78°C. 4-Methoxybenzonitrile (147 
mg, 1.1 mmol) in dry THF (2.0 mL) was added at -78°C and the mixture was stirred for 1 h 
at -78C, then at 20C for 16 h. Water (1.0 mL) was added. The mixture was diluted with 
CH2Cl2, washed thrice with brine and dried. Evaporation and washing (EtOH) gave 14c (8.1 
mg, 3%) as an off-white solid: mp 238-240°C; 1H NMR ((CD3)2SO) 3.82 (3 H, s, Me), 6.78 
(1 H, s, 4-H), 7.05 (2 H, d, J = 8.9 Hz, Ph 3,5-H2), 7.45 (1 H, m, 7-H), 7.57 (1 H, t, J = 8.9 
Hz, 6-H), 7.77 (2 H, d, J = 8.9 Hz, Ph 2,6-H2), 8.02 (1 H, d, J = 8.0 Hz, 8-H), 11.66 (1 H, br, 
NH); 13C NMR ((CD3)2SO) (HSQC / HMBC) 55.37 (Me), 93.59 (d, J = 5.3 Hz, 4-C), 
114.23 (Ph 3,5-C2), 117.52 (d, J = 19.6 Hz, 6-C), 122.74 (d, J = 3.2 Hz, 8-C), 125.84 (Ph 1-
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C), 126.24 (d, J = 3.6 Hz, 8a-C), 126.32 (d, J = 7.6 Hz, 7-C), 129.20 (d, J = 16.5 Hz, 4a-C), 
128.35 (Ph 2,6-C2), 141.19 (3-C), 157.19 (d, J = 247.5 Hz, 5-C), 160.41 (Ph 4-C), 161.82 (1-
C); 19F NMR ((CD3)2SO)  -122.20 (dd, J = 9.9, 5.2 Hz, F); MS m/z 561.1593 (2 M + Na)+ 
(C32H24F2N2NaO4 requires 561.1602), 292.0747 (M + Na)+ (C16H12FNNaO2 requires 
292.0750). 
5-Fluoro-3-(4-trifluoromethylphenyl)isoquinolin-1-one (14d). BuLi (1.6 M in hexanes, 0.9 
mL, 1.4 mmol) was added to dry Pri2NH (170 mg, 1.7 mmol) in dry THF (2.0 mL) at -78C 
and the mixture was stirred at -78C for 10 min. Compound 49 (250 mg, 1.4 mmol) in dry 
THF (2.0 mL) was added and the mixture was stirred for 1 h at -78°C. 4-Trifluoromethyl-
benzonitrile (236 mg, 1.4 mmol) in dry THF (2.0 mL) was added at -78°C and the mixture 
was stirred for 1 h at -78°C, then at 20°C for 16 h. Water (1.0 mL) was added. The mixture 
was diluted with CH2Cl2 (20 mL). The solid was collected by filtration and washed (EtOH) to 
give 14d (424 mg, 99%) as a white solid: mp >360°C; 1H NMR ((CD3)2SO) (COSY)  6.97 
(1 H, s, 4-H), 7.55 (1 H, td, J = 7.6, 5.7 Hz, 7-H), 7.63 (1 H, t, J = 8.7 Hz, 6-H), 7.86 (2 H, d, 
J = 8.1 Hz, Ph 3,5-H2), 8.05 (3 H, m, Ph 2,6-H2 + 8-H), 11.92 (1 H, br, NH); 13C NMR 
((CD3)2SO) (HSQC / HMBC) d 96.30 (d, J = 4.9 Hz, 4-C), 117.86 (d, J = 19.5 Hz, 6-C), 
122.83 (d, J = 3.4 Hz, 8-C), 124.07 (q, J = 270.1 Hz, CF3), 125.63 (q, J = 3.5 Hz, Ph 3,5-H2), 
126.59 (d, J = 16.3 Hz, 4a-C), 126.91 (8a-C), 127.52 (d, J = 7.6 Hz, 7-C), 127.99 (Ph 2,6-C2), 
129.58 (q, J = 31.9 Hz, Ph 4-C), 137.47 (1-C), 139.86 (3-C), 157.44 (d, J = 248.5 Hz, 5-C), 
161.70 (1-C); 19F NMR (DMSO)  -61.19 (3 F, s, CF3), -121.55 (1 F, m, F); MS m/z 
306.0559 (M - H)- (C16H8F4NO requires 306.0548) 
3-(4-Chlorophenyl)-5-fluoroisoquinolin-1-one (14f). BuLi (1.6 M in hexanes, 0.9 mL, 1.4 
mmol) was added to dry Pri2NH (170 mg, 1.7 mmol) in dry tetrahydrofuran (2.0 mL) at -78C 
and the mixture was stirred at this temperature for 10 min. Compound 49 (250 mg, 1.4 mmol) 
in dry THF (2.0 mL) was added and the mixture was stirred for 1 h at -78°C. 4-Chlorobenzo-
nitrile (190 mg, 1.4 mmol) in dry THF (2.0 mL) was added at -78°C and the mixture was 
stirred for 1 h at -78°C, then at 20°C for 16 h. Water (1.0 mL) was added. The mixture was 
diluted with CH2Cl2 (20 mL). The solid was collected by filtration and washed (EtOH) to 
give 14f (269 mg, 71%) as a white solid: mp 296-297°C; 1H NMR ((CD3)2SO) (COSY)  
6.86 (1 H, s, 4-H), 7.49 (1 H, m, 7-H), 7.57 (3 H, m, 6-H + Ph 3,5-H2), 7.84 (2 H, d, J = 8.6 
Hz, Ph 2,6-H2), 8.05 (1 H, d, J = 7.9 Hz, 8-H), 11.63 (1 H, br, N-H); 13C NMR ((CD3)2SO) 
(HSQC / HMBC)  94.91 (d, J = 5.4 Hz, 4-C), 117.36 (d, J = 19.6 Hz, 6-C), 122.53 (d, J = 
3.5 Hz, 8-C), 126.73 (d, J = 8.0 Hz, 7-C), 126.52 (8a-C), 126.65 (d, J = 16.2 Hz, 4a-C), 
128.51 (Ph 3,5-C2), 128.57 (Ph 2,6-C2), 132.26 (Ph 1-C), 134.15 (Ph 4-C), 140.00 (3-C), 
157.15 (d, J = 248.4 Hz, 5-C), 161.42 (1-C); 19F NMR ((CD3)2SO)  -122.79 (m, F); MS m/z 
272.0762 (M - H)- (C15H835ClFNO requires 272.0784). 
3-(4-Bromophenyl)-5-fluoroisoquinolin-1-one (14g). BuLi (1.6 M in hexanes, 0.64 mL, 1.2 
mmol) was added to dry Pri2NH (121 mg, 1.2 mmol) in dry THF (2.0 mL) at -78C and the 
mixture was stirred at -78C for 10 min. Compound 49 (180 mg, 1.0 mmol) in dry THF (2.0 
mL) was added and the mixture was stirred for 1 h at -78°C. 4-Bromobenzonitrile (186 mg, 
1.0 mmol) in dry THF (2.0 mL) was added at -78°C and the mixture was stirred for 1 h at -
78°C, then at 20°C for 16 h. Water (1.0 mL) was added. The mixture was diluted with 
CH2Cl2 (20 mL). The solid was collected by filtration and washed (EtOH) to give 11g (238 
mg, 61%) as a white solid: mp >360°C; 1H NMR ((CD3)2SO) (COSY) 6.86 (1 H, s, 4-H), 
7.47 (1 H, m, 7-H), 7.52 (1 H, t, J = 8.1 Hz, 6-H), 7.67 (2 H, d, J = 8.6 Hz, Ph 2,6-H2), 7.78 
(2 H, d, J = 8.6 Hz, Ph 3,5-H2), 8.03 (1 H, d, J = 7.9 Hz, 8-H), 11.87 (1 H, bs, N-H); 13C 
NMR ((CD3)2SO)  (HSQC / HMBC) 94.61 (d, J = 5.1 Hz, 4-C), 117.08 (d, J = 19.3 Hz, 6-
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C), 122.60 (d, J = 3.5 Hz, 8-C), 122.66 (Ph 4-C), 126.45 (d, J = 7.9 Hz, 7-C), 126.53 (8a-C), 
126.80 (d, J = 16.3 Hz, 4a-C), 128.85 (Ph 3,5-C2), 131.45 (Ph 2,6-C2), 133.27 (Ph 1-C), 
140.87 (3-C), 157.20 (d, J = 248.3 Hz, 5-C), 162.10 (1-C); 19F NMR ((CD3)2SO)  -121.89 
(m, F)MS m/z 317.9760 (M – H)- (C15H881BrFNO requires 317.9753), 315.9773 (M - H)- 
(C15H879BrFNO requires 315.9773). 
5-Fluoro-3-(pyridin-4-yl)isoquinolin-1-one (14h). BuLi (1.6 M in hexanes, 0.7 mL, 1.1 
mmol) was added to dry Pri2NH (131 mg, 1.3 mmol) in dry THF (2.0 mL) at -78C and the 
mixture was stirred at -78C for 10 min. Compound 49 (200 mg, 1.1 mmol) in dry THF (2.0 
mL) was added and the mixture was stirred for 1 h at -78°C. 4-Cyanopyridine (114 mg, 1.1 
mmol) in dry THF (2.0 mL) was added and the mixture was stirred for 1 h at -78C, then at 
20C for 16 h. Water (1.0 mL) was added. The mixture was diluted with CH2Cl2, washed 
thrice with brine and dried. Evaporation and washing (EtOH) gave 14h (264 mg, 99%) as a 
white solid: mp >360°C; IR max 3435, 1675, 1244 cm-1; 1H NMR ((CD3)2SO)  7.10 (1 H, s, 
4-H), 7.55 (1 H, m, 7-H), 7.64 (1 H, t, J = 8.0 Hz, 6-H), 7.86 (2 H, d, J = 6.2 Hz, pyridine 
3,5-H2), 8.06 (1 H, d, J = 7.8 Hz, 8-H), 8.70 (2 H, d, J = 6.2 Hz, pyridine 2,6-H2), 11.90 (1 H, 
br, NH); 13C NMR ((CD3)2SO) (HSQC / HMBC)  96.61 (4-C), 117.89 (d, J = 19.8 Hz, 6-C), 
121.10 (pyridine 3,5-C2), 122.86 (8-C), 126.40 (d, J = 15.9 Hz, 4a-C), 127.26 (8a-C), 127.86 
(d, J = 7.9 Hz, 7-C), 138.75 (3-C), 140.57 (pyridine 4-C), 150.19 (pyridine 2,6-C2), 157.52 
(d, J = 248.8 Hz, 5-C), 161.79 (1-C); 19F NMR ((CD3)2SO)  -121.19 (m, F); MS m/z 
239.0622 (M - H)- (C14H8FN2O requires 239.0621). 
5-Methoxy-3-(4-methylphenyl)isoquinolin-1-one (15b). BuLi (1.6 M in hexanes, 0.8 mL, 
1.3 mmol) was added to dry Pri2NH (156 mg, 1.55 mmol) in dry THF (2.0 mL) at -78C and 
the mixture was stirred at -78C for 10 min. Compound 51 (250 mg, 1.3 mmol) in dry THF 
(2.0 mL) was added and the mixture was stirred for 1 h at -78°C. 4-Methylbenzonitrile (151 
mg, 1.3 mmol) in dry THF (2.0 mL) was added at -78°C and the mixture was stirred for 1 h at 
-78C, then at 20C for 16 h. Water (1.0 mL) was added. The mixture was diluted with 
CH2Cl2, washed thrice with brine and dried. Evaporation and recrystallisation (EtOH) gave 
15b (16 mg, 5%) as pale yellow crystals: mp 249-251°C; 1H NMR ((CD3)2SO) (COSY) 
2.36 (3 H, s, Ph-Me), 3.94 (3 H, s, OMe), 6.92 (1 H, s, 4-H), 7.25 (1 H, dd, J = 8.0, 0.9 Hz, 
6-H), 7.29 (2 H, d, J = 7.9 Hz, Ph 3,5-H2), 7.41 (1 H, t, J = 8.0 Hz, 7-H), 7.66 (2 H, d, J = 8.2 
Hz, Ph 2,6-H2), 7.77 (1 H, dt, J = 8.0, 0.8 Hz, 8-H), 11.54 (1 H, br, N-H); 13C NMR 
((CD3)2SO) (HSQC / HMBC) 20.81 (Me), 55.92 (OMe), 96.35 (4-C), 112.22 (6-C), 118.23 
(8-C), 125.66 (4a-C), 126.51 (Ph 2,6-C2), 126.64 (7-C), 128.52 (8a-C), 129.40 (Ph 3,5-C2), 
131.22 (Ph 1-C), 138.88 (3-C), 139.62 (Ph 4-C), 154.33 (5-C), 162.54 (1-C); MS m/z 
288.0995 (M + Na)+ (C17H15NaNO2 requires 288.1001). 
3-(4-(1,1-Dimethylethyl)phenyl)-5-methoxyisoquinolin-1-one (15c). BuLi (2.5 M in 
hexanes, 0.42 mL, 1.0 mmol) was added to dry Pri2NH (126 mg, 1.2 mmol) in dry THF (2.0 
mL) at -78C and the mixture was stirred at -78C for 10 min. Compound 51 (200 mg, 1.0 
mmol) in dry THF (2.0 mL) was added and the mixture was stirred for 1 h at -78°C. 4-(1,1-
Dimethylethyl)benzonitrile (164 mg, 1.0 mmol) in dry THF (2.0 mL) was added at -78°C and 
the mixture was stirred for 1 h at -78C, then at 20C for 16 h. H2O (1.0 mL) was added and 
the mixture was diluted with CH2Cl2 and washed thrice with brine. Drying, evaporation and 
washing (EtOH) gave 15c (72 mg, 23%) as a white solid: mp 249-250°C; IR νmax 3451, 1633 
cm-1; 1H NMR ((CD3)2SO) (COSY)  1.33 (9 H, s, But), 3.96 (3 H, s, OMe), 6.95 (1 H, s, 4-
H), 7.27 (1 H, d, J = 7.9 Hz, 6-H), 7.44 (1 H, t, J = 8.0 Hz, 7-H), 7.52 (2 H, d, J = 8.5 Hz, Ph 
3,5-H2), 7.72 (2 H, d, J = 8.5 Hz, Ph 2,6-H2), 7.79 (1 H, d, J = 8.0 Hz, 8-H), 11.54 (1 H, br, 
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NH); 13C NMR ((CD3)2SO) (HSQC / HMBC)  30.96 (C(CH3)3), 34.43 (CMe3), 55.90 
(OMe), 96.43 (4-C), 112.19 (6-C), 118.19 (8-C), 125.59 (Ph 3,5-C2), 125.59 (8a-C), 126.30 
(Ph 3,5-C2), 126.63 (7-C), 128.46 (4a-C), 131.19 (Ph 1-C), 139.45 (3-C), 151.85 (Ph 4-C), 
154.28 (5-C), 162.47 (1-C); MS m/z 308.1639 (C20H22NO2 requires 308.1652). 
5-Methoxy-3-(4-trifluoromethylphenyl)isoquinolin-1-one (15d). BuLi (1.6 M in hexanes, 
0.8 mL, 1.3 mmol) was added to dry Pri2NH (157 mg, 1.55 mmol) in dry THF (2.0 mL) at -
78C and the mixture was stirred at -78C for 10 min. Compound 51 (250 mg, 1.3 mmol) in 
dry THF (2.0 mL) was added and the mixture was stirred for 1 h at -78°C. 4-Trifluoromethyl-
benzonitrile (221 mg, 1.3 mmol) in dry THF (2.0 mL) was added at -78°C and the mixture 
was stirred for 1 h at -78°C, then at 20°C for 16 h. Water (1.0 mL) was added. The mixture 
was extracted with CH2Cl2. The extract was washed thrice with brine and dried. Evaporation 
and recrystallisation (EtOH) gave 15d (113 mg, 27%) as white crystals: mp 259-260°C; 1H 
NMR ((CD3)2SO) (COSY)  3.95 (3 H, s, Me), 7.04 (1 H, s, 4-H), 7.30 (1 H, d, J = 8.0 Hz, 6-
H), 7.48 (1 H, t, J = 8.0 Hz, 7-H), 7.80 (1 H, d, J = 8.0 Hz, 8-H), 7.83 (2 H, d, J = 8.3 Hz, 
Ph3,5-H2), 7.98 (2 H, d, J = 8.2 Hz, Ph 2,6-H2), 11.75 (1 H, bs, N-H); 13C NMR ((CD3)2SO) 
(HSQC / HMBC)  55.93 (Me), 98.28 (4-C), 112.46 (6-C), 118.18 (8-C), 124.03 (q, J = 
270.5 Hz, CF3), 125.51 (q, J = 3.8 Hz, Ph 3,5-C2), 126.15 (4a-C), 127.40 (7-C), 127.49 (Ph 
2,6-C2), 127.93 (8a-C), 129.14 (q, J = 31.9 Hz, Ph 4-C), 137.85 (Ph 1-C), 137.96 (3-C), 
154.54 (5-C), 162.30 (1-C); 19F NMR ((CD3)2SO)  -61.20 (s, CF3); MS m/z 318.0740 (M - 
H)- (C17H11F3NO2 requires 318.0747). 
3-(4-Chlorophenyl)-5-methoxyisoquinolin-1-one (15e). BuLi (1.6 M in hexanes, 0.8 mL, 
1.3 mmol) was added to dry Pri2NH (156 mg, 1.55 mmol) in dry THF (2.0 mL) at -78C and 
the mixture was stirred at -78C for 10 min. Compound 51 (250 mg, 1.3 mmol) in dry THF 
(2.0 mL) was added and the mixture was stirred for 1 h at -78°C. 4-Chlorobenzonitrile (178 
mg, 1.3 mmol) in dry THF (2.0 mL) was added -78C and the mixture was stirred for 1 h at -
78C, then at 20C for 16 h. Water (1.0 mL) was added. The mixture was diluted with 
CH2Cl2, washed thrice with brine and dried. Evaporation and washing (EtOH) gave 15e (86 
mg, 23%) as an off-white solid: mp 243-245°C; 1H NMR ((CD3)2SO) (COSY)  4.00 (3 H, s, 
Me), 7.01 (1 H, s, 4-H), 7.33 (1 H, d, J = 7.4 Hz, 6-H), 7.50 (1 H, t, J = 8.0 Hz, 7-H), 7.60 (2 
H, d, J = 6.8 Hz, Ph 3,5-H2), 7.84 (3 H, m, 8-H + Ph 2,6-H2), 11.71 (1 H, br, N-H); 13C NMR 
((CD3)2SO) (HSQC / HMBC) 55.95 (Me), 97.34 (4-C), 112.39 (6-C), 118.23 (8-C), 125.89 
(4a-C), 127.11 (7-C), 128.20 (8a-C), 128.56 (Ph 2,6-C2), 128.79 (Ph 3,5-C2), 132.88 (Ph 1-
C), 133.91 (Ph 4-C), 138.42 (3-C), 154.44 (5-C), 162.44 (1-C); MS m/z 308.0413 (M + Na)+ 
(C16H1235ClNNaO2 requires 308.0449). 
3-(4-Bromophenyl)-5-methoxyisoquinolin-1-one (15f). BuLi (1.6 M in hexanes, 0.70 mL, 
1.1 mmol) was added to dry Pri2NH (131 mg, 1.3 mmol) in dry THF (2.0 mL) at -78C and 
the mixture was stirred at -78C for 10 min. Compound 51 (200 mg, 1.0 mmol) in dry THF 
(2.0 mL) was added and the mixture was stirred for 1 h at -78°C. 4-Bromobenzonitrile (188 
mg, 1.0 mmol) in dry THF (2.0 mL) was added and the mixture was stirred for 1 h at -78°C, 
then at 20°C for 16 h. Water (1.0 mL) was added. The mixture was diluted with CH2Cl2, 
washed thrice with brine and dried. Evaporation and washing (EtOH) gave 15f (48 mg, 14%) 
as a white solid: mp 263-264°C; IR max 3526, 1665, 739 cm-1; 1H NMR ((CD3)2SO)  3.94 
(3 H, s, Me), 6.95 (1 H, s, 4-H), 7.27 (1 H, d, J = 7.8 Hz, 6-H), 7.45 (1 H, t, J = 8.0 Hz, 7-H), 
7.69 (4 H, m, Ph 2,3,5,6-H4), 7.78 (1 H, d, J = 8.0 Hz, 8-H), 11.64 (1 H, br, NH); 13C NMR 
((CD3)2SO) (HSQC / HMBC)  55.95 (Me), 97.30 (4-C), 112.39 (6-C), 118.23 (8-C), 122.58 
(Ph 4-C), 125.90 (4a-C), 127.11 (7-C), 128.19 (8a-C), 128.79 (Ph 2,6-C2), 131.70 (Ph 3,5-
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C2), 133.24 (Ph 1-C), 138.49 (3-C), 154.44 (5-C), 162.44 (1-C); MS m/z 682.9978 (2 M + 
Na) (C32H2479Br81BrN2NaO4 requires 682.9981); 661.0145 (2 M + H) (C32H2579Br81BrN2O4 
requires 661.0161); 351.9959 (M + Na) (C16H1279BrNNaO2 requires 351.9949); 332.0098 (M 
+ H)+ (C16H1381BrNO2 requires 332.0110); 330.0113 (M + H)+ (C16H1379BrNO2 requires 
330.0130). 
5-Methoxy-3-(pyridin-4-yl)isoquinolin-1-one (15g). BuLi (1.6 M in hexanes, 0.80 mL, 1.3 
mmol) was added to dry Pri2NH (157 mg, 1.55 mmol) in dry THF (2.0 mL) at -78C and the 
mixture was stirred at -78C for 10 min. Compound 51 (250 mg, 1.3 mmol) in dry THF (2.0 
mL) was added and the mixture was stirred for 1 h at -78°C. 4-Cyanopyridine (135 mg, 1.3 
mmol) in dry THF (2.0 mL) was added and the mixture was stirred for 1 h at -78°C, then at 
20°C for 16 h. Water (1.0 mL) was added. The mixture was diluted with CH2Cl2, washed 
thrice with brine and dried. Evaporation and washing (EtOH) gave 15g (284 mg, 87%) as a 
white solid: mp >360°C; IR max 3431, 1673 cm-1; 1H NMR ((CD3)2SO) (COSY)  3.96 (3 H, 
s, Me), 7.16 (1 H, s, 4-H), 7.31 (1 H, d, J = 7.9 Hz, 6-H), 7.50 (1 H, t, J = 8.0 Hz, 7-H), 7.80 
(3 H, m, 8-H + pyridine 3,5-H2), 8.66 (2 H, d, J = 6.1 Hz, pyridine 2,6-H2), 11.74 (1 H, br, 
NH); 13C NMR ((CD3)2SO) (HSQC / HMBC)  56.04 (Me), 98.74 (4-C), 112.64 (6-C), 
118.26 (8-C), 120.76 (pyridine 3,5-C2), 126.55 (4a-C), 127.70 (8a-C), 127.93 (7-C), 136.82 
(pyridine 4-C), 140.86 (3-C), 150.19 (pyridine 2,6-C2), 154.70 (5-C), 162.39 (1-C); MS m/z 
253.0972 (M + H) (C15H13N2O2 requires 253.0977). 
3-(Benzo-1,3-dioxol-5-yl)-5-methoxyisoquinolin-1-one (15h). BuLi (1.6 M in hexanes, 0.7 
mL, 1.1 mmol) was added to dry Pri2NH (125 mg, 1.2 mmol) in dry THF (2.0 mL) at -78C 
and the mixture was stirred at -78C for 10 min. Compound 51 (200 mg, 1.0 mmol) in dry 
THF (2.0 mL) was added and the mixture was stirred for 1 h at -78°C. 5-Cyanobenzo-1,3-
dioxole (152 mg, 1.0 mmol) in dry THF (2.0 mL) was added at -78 °C and the mixture was 
stirred for 1 h at -78C, then at 20C for 16 h. H2O (1.0 mL) was added. The mixture was 
diluted with CH2Cl2, washed thrice with brine and dried. Evaporation and washing (EtOH) 
gave 15h (32 mg, 11%) as an off-white solid: mp 282-284°C; IR νmax 3445, 1631 cm-1; 1H 
NMR ((CD3)2SO)  3.93 (3 H, s, Me), 6.09 (2 H, s, CH2), 6.86 (1 H, s, 4-C), 7.01 (1 H, d, J = 
8.1 Hz, Ph 5-H), 7.25 (1 H, d, J = 7.2 Hz, 6-H), 7.27 (1 H, dd, J = 8.2, 1.9 Hz, Ph 6-H), 7.33 
(1 H, d, J = 1.8 Hz, Ph 2-H), 7.40 (1 H, t, J = 8.0 Hz, 7-H), 7.74 (1 H, d, J = 8.0 Hz, 8-H), 
11.45 (1 H, br, NH); 13C NMR ((CD3)2SO) (HSQC / HMBC / DEPT)  55.91 (OMe), 96.29 
(4-C), 101.53 (CH2), 107.03 (Ph 4-C), 108.54 (Ph 7-C), 112.17 (6-C), 118.21 (8-C), 120.92 
(Ph 6-C), 125.54 (4a-C), 126.52 (7-C), 128.20 (Ph 5-C), 128.54 (8a-C), 139.42 (3-C), 147.72 
(Ph 7a-C), 148.16 (Ph 3a-C), 154.27 (5-C), 162.51 (1-C); MS m/z 613.1595 (2 M + Na) 
(C34H26N2NaO8 requires 613.1587); 591.1768 (2 M + H) (C34H27N2O8 requires 591.1767); 
318.0765 (M + Na) (C17H13NNaO4 requires 318.0742); 296.0907 (M + H) (C17H14NO4 
requires 296.0923). 
5-Methoxy-3-(thiophen-3-yl)isoquinolin-1-one (15i). BuLi (2.5 M in hexanes, 0.42 mL, 1.0 
mmol) was added to dry Pri2NH (126 mg, 1.24 mmol) in dry THF (2.0 mL) at -78C and the 
mixture was stirred at -78C for 10 min. Compound 51 (200 mg, 1.0 mmol) in dry THF (2.0 
mL) was added and the mixture was stirred for 1 h at -78°C. 3-Cyanothiophene (112 mg, 1.0 
mmol) in dry THF (2.0 mL) was added at -78°C and the mixture was stirred for 1 h at -78C, 
then at 20C for 16 h. H2O (1.0 mL) was added. The mixture was diluted with CH2Cl2 and 
washed thrice with brine. Evaporation and washing (EtOH) gave 15i (37 mg, 14%) as a pale 
buff solid: mp 286-287°C; IR νmax 3503, 1652, 746 cm-1; 1H NMR ((CD3)2SO) (COSY)  
3.94 (3 H, s, Me), 7.04 (1 H, s, 4-H), 7.24 (1 H, d, J = 7.9 Hz, 6-H), 7.40 (1 H, t, J = 8.0 Hz, 
7-H), 7.66 (2 H, m, thiophene 4,5-H2), 7.75 (1 H, d, J = 8.0 Hz, 8-H), 8.23 (1 H, d, J = 1.2 
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Hz, thiophene 2-H), 11.48 (1 H, br, NH); 13C NMR ((CD3)2SO) (HSQC / HMBC)  55.88 
(Me), 95.99 (4-C), 112.28 (6-C), 118.24 (8-C), 123.36 (thiophene 2-C), 125.71 (8a-C), 
125.78 (thiophene 5-C), 126.63 (7-C), 127.44 (thiophene 4-C), 128.44 (4a-C), 134.71 (thio-
phene 1-C), 135.20 (3-C), 154.30 (5-C), 162.29 (1-C); MS m/z 280.0399 (C14H11NNaO2S 
requires 280.0409). 
5-Hydroxy-3-(4-trifluoromethylphenyl)isoquinolin-1-one (16b). Compound 15d (51 mg, 
0.16 mmol) was heated with BBr3 in CH2Cl2 (1.0 M, 4.0 mL) at reflux for 16 h. The evapora-
tion residue was treated with aq. NaOH (2.5 M, 3.5 mL) at 0°C and the mixture was stirred at 
20C for 3 h. The solution was acidified with aq. HCl (2 M). The solid was collected by filt-
ration. Chromatography (EtOAc / petroleum ether 2:3 → 1:1) gave 16b (3.9 mg, 8%) as a 
pale buff solid: mp 258-260°C; IR max 3399, 3197, 1640, 1329, 1113, 1068 cm-1; 1H NMR 
(CD3OD)  7.14 (1 H, dd, J = 7.8, 1.0 Hz, 6-H), 7.29 (1 H, s, 4-H), 7.37 (1 H, t, J = 7.9 Hz, 
7-H), 7.81 (3 H, m, 8-H + Ph 3,5-H2), 7.92 (2 H, d, J = 8.2 Hz, Ph 2,6-H2); 13C NMR 
(CD3OD) (HSQC / HMBC)  102.03 (4-C), 117.66 (6-C), 118.54 (8-C), 125.54 (q, J = 268.9 
Hz, CF3), 126.94 (q, J = 3.8 Hz, Ph 3,5-C2), 127.41 (4a-C), 128.36 (Ph 2,6-C2), 128.90 (7-C), 
129.23 (8a-C), 131.88 (q, J = 32.4 Hz, Ph 4-C), 138.33 (3-C), 139.73 (Ph 1-C), 154.84 (5-C), 
165.60 (1-C); MS m/z 328.0568 (M + Na)+ (C16H10F3NNaO2 requires 328.0561), 306.0740 
(M + H)+ (C16H11F3NO2 requires 306.0742); MS m/z 304.0577 (M - H)- (C16H9F3NO2 
requires 304.0585). 
5-Nitro-3-(4-trifluoromethylphenyl)isoquinolin-1-one (22i). Compound 30i (78 mg, 220 
mol) was stirred with HBr in AcOH (33%, 3.5 mL) at 65°C for 7 h. Evaporation yielded 
221 (34.5 mg, 47%) as a yellow solid: mp: 292-294C; 1H NMR ((CD3)2SO)  7.30 (1 H, s, 
4-H), 7.70 (1 H, t, J = 8.0 Hz, 7-H), 7.89 (2 H, d, J = 8.5 Hz, Ph 3,5-H2), 7.99 (2 H, d, J = 8.5 
Hz, Ph 2,6-H2), 8.49 (1 H, d, J = 7.5 Hz, 8-H), 8.60 (1 H, d, J = 7.5 Hz, 6-H), 12.26 (1 H, br, 
N-H); 13C NMR ((CD3)2SO) (HSQC / HMBC) 98.63 (4-C), 124.01 (q, J = 270.8 Hz, CF3), 
125.81 (q, J = 3.6 Hz, Ph 3,5-C2), 126.36 (7-C), 126.89 (8a-C), 128.27 (Ph 2,6-C2), 129.99 
(8-C), 130.04 (q, J = 31.8 Hz, Ph 4-C), 130.59 (4a-C), 133.19 (6-C), 137.44 (Ph 1-C), 142.64 
(3-C), 144.94 (5-C), 161.33 (1-C); 19F NMR ((CD3)2SO)  -61.22 (s, CF3); MS m/z 333.0493 
(M - H)- (C16H8F3N2O3 requires 333.0493). 
3-(4-Fluorophenyl)-5-nitroisoquinolin-1-one (22j). Compound 30j (16 mg, 50 mol) was 
stirred with HBr in AcOH (33%, 1.0 mL) at 65°C for 7 h. Evaporation yielded 22j (7.8 mg, 
55%) as a yellow solid: mp >360C; 1H NMR ((CD3)2SO)  7.19 (1 H, s, 4-H), 7.36 (2 H, t, J 
= 8.6 Hz, Ph 3,5-H2), 7.65 (1 H, J = 7.9 Hz, 7-H), 7.84 (2 H, dd, J = 8.2, 5.3 Hz, Ph 2,6-H2), 
8.46 (1 H, d, J = 7.8 Hz, 8-H), 8.59 (1 H, d, J = 7.7 Hz, 6-H), 11.95 (1 H, br, NH); 13C NMR 
((CD3)2SO) (HSQC / HMBC) 96.94 (4-C), 115.56 (d, J = 21.8 Hz, Ph 3,5-C2), 125.41 (7-
C), 126.38 (8a-C), 129.36 (8-C), 129.43 (Ph 2,6-C2), 129.86 (4a-C), 130.63 (Ph 1-C), 132.83 
(6-C), 143.07 (3-C), 144.55 (5-C), 160.99 (1-C), 162.94 (d, J = 246.6 Hz, Ph 4-C); 19F NMR 
((CD3)2SO)  -110.96m, F); MS m/z 283.0524 (M - H)- (C15H8FN2O3 requires 283.0524). 
1,3-Dichloro-5-nitroisoquinoline (27). Aq. HNO3 (67%, 430 mg) in conc. H2SO4 (3.0 mL) 
was added dropwise to 1,3-dichloroisoquinoline 26 (1.00 g, 5.1 mmol) in conc. H2SO4 (5.0 
mL) at 5C. The mixture was stirred at 0-5°C for 2 h, then poured onto ice. The precipitate 
was collected, washed (H2O), dried and recrystallised (EtOAc / petroleum ether) to give 27 
(1.12 g, 91%) as a yellow powder: mp 168-170°C (lit.2 mp 168-170C); 1H NMR (CDCl3)  
7.80 (1 H, t, J = 7.8 Hz, 7-H), 8.55 (1 H, s, 4-H), 8.62 (1 H, dd, J = 7.8, 1.8 Hz, 6-H), 8.72 (1 
H, dt, J = 8.5, 1.1 Hz, 8-H); 13C NMR (CDCl3) (HSQC / HMBC)  115.16 (4-C), 126.00 (4a-
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C), 126.64 (7-C), 129.63 (6-C), 131.60 (8a-C), 133.12 (8-C), 144.01 (5-C), 147.08 (3-C), 
151.75 (1-C). 
1-Methoxy-3-(3-methylphenyl)-5-nitroisoquinoline (30b). Compound 28 (0.84 g, 3.5 
mmol), Pd2dba3 (0.18 g, 0.35 mmol), SPhos (0.14 g, 0.70 mmol), K3PO4 (1.5 g, 7.1 mmol) 
and 3-methylphenylboronic acid (720 mg 5.3 mmol) were placed in a dry flask. Degassed 
toluene (20 mL) was added and the mixture was stirred at 100°C for 16 h. Evaporation and 
chromatography (hexane / EtOAc 15:1) gave 30b (700 mg, 67%) as yellow crystals: mp 166-
169C; 1H NMR (CDCl3)  2.36 (3 H, s, ArMe), 4.11 (3 H, s, OMe), 7.13 (1 H, d, J = 7.8 Hz, 
Ar 4-H), 7.27 (1 H, t, J = 7.8 Hz, Ar 5-H), 7.36 (1 H, t, J = 7.4 Hz, 7-H), 7.83 (1 H, s, Ar 2-
H), 7.85 (1 H, d, J = 7.6 Hz Ar 6-H), 8.23-8.26 (2 H, m, 6-H and 4-H), 8.39 (1 H, d, J = 7.4 
Hz 8-H); 13C NMR (HMBC / HMQC)  21.6 (ArMe), 54.0 (OMe), 104.9 (4-C), 124.2 (Ar 6-
C), 124.2 (7-C), 127.6 (Ar 2-C) 128.5 (6-C), 128.6 (Ar 5-C), 130.1 (Ar 4-C), 131.1 (8-C), 
131.3 (Cq), 138.2 (Ar 1-C), 138.5 (Cq),151.8 (3-C), 151.9 (5-C), 160.3 (1-C); MS m/z 
295.1076 (M + H)+ (C17H15N2O3 requires 295.1083). 
1-Methoxy-3-(2-methoxyphenyl)-5-nitroisoquinoline (30d). Degassed PhMe (3.0 mL) was 
added to 28 (102 mg, 430 mol), Pd2dba3 (11.5 mg, 13 mol), SPhos (23 mg, 56 mol), 2-
methoxybenzeneboronic acid (150 mg, 1.0 mmol) and K3PO4 (204 mg, 1.0 mmol) in a dry 
flask. The mixture was stirred at 100°C for 16 h. The evaporation residue, in CHCl3, was fil-
tered. Chromatography (EtOAc / petroleum ether 1:99) gave 30d (74 mg, 58%) as a yellow 
solid: mp 115-117°C; 1H NMR (CDCl3)  3.97 (3 H, s, PhOMe), 4.23 (3 H, s, 1-OMe), 7.06 
(1 H, d, J = 8.3 Hz, Ph 3-H), 7.11 (1 H, td, J = 7.6, 1.1 Hz, Ph 4-H), 7.39 (1 H, td, J = 7.8, 1.8 
Hz, Ph 5-H), 7.55 (1 H, t, J = 7.9 Hz, 7-H), 8.15 (1 H, dd, J = 7.8, 1.8 Hz, Ph 6-H), 8.43 (1 H, 
dd, J = 7.8, 1.3 Hz, 6-H), 8.59 (1 H, dt, J = 8.2, 1.1 Hz, 8-H), 8.78 (1 H, s, 4-H); 13C NMR 
(CDCl3) (HSQC / HMBC)  54.06 (1-OMe), 55.71 (PhOMe), 110.12 (4-C), 111.79 (Ph 3-C), 
119.70 (8a-C), 120.87 (Ph 4-C), 124.36 (7-C), 128.18 (6-C), 130.17 (Ph 5-C), 130.91 (8-C), 
131.22 (Ph 6-C), 146.81 (5-C), 157.82 (Ph 2-C), 160.04 (1-C); MS m/z 333.0858 (M + Na)+ 
(C17H14N2NaO4 requires 333.0852), 311.1030 (M + H)+ (C17H15N2O4 requires 311.1034). 
1-Methoxy-3-(3-methoxyphenyl)-5-nitroisoquinoline (30e). Degassed PhMe (3.0 mL) was 
added to 28 (103 mg, 430 mol), Pd2dba3 (11.6 mg, 13 mol), SPhos (22 mg, 54 mol), 3-
methoxybenzeneboronic acid (153 mg, 1.0 mmol) and K3PO4 (203 mg, 0.96 mmol). The mix-
ture was stirred at 100°C for 16 h. The evaporation residue, in CHCl3, was filtered. Chrom-
atography (EtOAc / petroleum ether 1:99) gave 30e (81 mg, 81%) as a yellow solid: mp 87-
90°C; 1H NMR (CDCl3)  3.93 (3 H, s, PhOMe), 4.28 (3 H, s, 1-OMe), 7.00 (1 H, m, Ph 6-
H), 7.42 (1 H, t, J = 8.0 Hz, Ph 5-H), 7.57 (1 H, t, J = 8.0 Hz, 7-H), 7.78 (2 H, m, Ph 2,4-H2), 
8.48 (1 H, dd, J = 7.8, 1.3 Hz, 6-H), 8.51 (1 H, s, 4-H), 8.61 (1 H, dt, J = 8.2, 1.0 Hz, 8-H); 
13C NMR (CDCl3) (HSQC / HMBC) 54.16 (PhOMe), 56.00 (1-OMe), 105.38 (4-C), 112.98 
(Ph 4-C), 114.79 (Ph 6-C), 119.62 (Ph 2-C), 124.53 (7-C), 128.54 (6-C), 129.76 (Ph 5-C), 
131.20 (8-C), 139.72 (Ph 3-C), 144.35 (5-C), 160.26 (1-C); MS m/z 311.1030 (M + H)+ 
(C17H15N2O4 requires 311.1034). 
1-Methoxy-5-nitro-3-(3-trifluoromethylphenyl)isoquinoline (30h). Method A. Degassed 
PhMe (3.0 mL) was added to 28 (101 mg, 420 mol), Pd2dba3 (41 mg, 45 mol), SPhos (40 
mg, 100 mol), 3-trifluoromethylbenzeneboronic acid (161 mg, 850 mol) and K3PO4 (179 
mg, 840 mol). The mixture was stirred at 100°C for 16 h. The evaporation residue, in 
CHCl3, was filtered. Chromatography (Et2O / petroleum ether 1:199) gave 30h (80.4 mg, 
55%) as a yellow solid: mp 135-137°C; 1H NMR (CDCl3) 4.29 (3 H, s, Me), 7.62 (2 H, m, 
7-H + Ph 5-H), 7.70 (1 H, d, J = 8.0 Hz, Ph 4-H), 8.34 (1 H, d, J = 7.9 Hz, Ph 6-H), 8.47 (1 
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H, s, Ph 2-H), 8.49 (1 H, dd, J = 7.7, 1.2 Hz, 6-H), 8.53 (1 H, s, 4-H), 8.62 (1 H, dt, J = 7.2, 
1.0 Hz, 8-H); 13C NMR (CDCl3) (HSQC / HMBC) 54.31(Me), 105.70 (4-C), 120.30 (8a-
C), 123.98 (q, J = 3.9 Hz, Ph 2-C), 124.19 (q, J = 270.4 Hz, CF3), 125.08 (7-C), 125.84 (q, J 
= 3.9 Hz, Ph 4-C), 126.89, 128.77 (6-C), 128.78, 29.20 (Ph 5-C), 130.12 (Ph 6-C), 131.27 (8-
C), 131.27 (4a-C), 131.30 (q, J = 32.3 Hz, Ph 3-C), 139.47 (Ph 1-C), 145.04 (5-C), 150.25 (3-
C), 160.75 (1-C); 19F NMR (CDCl3)  -62.66 (s, CF3); MS m/z 349.0826 (M + H)+ 
(C17H12F3N2O3 requires 349.0802). 
1-Methoxy-5-nitro-3-(3-trifluoromethylphenyl)isoquinoline (30h). Method B. Dry DMF 
(8.0 mL) was added to 37 (300 mg, 1.1 mmol), Pd2dba3 (97 mg, 106 mol), SPhos (99 mg, 
0.21 mmol), 3-trifluoromethyl)benzeneboronic acid (403 mg, 2.1 mmol) and K3PO4 (675 mg, 
3.2 mmol) and the mixture was stirred at 135°C for 16 h. The mixture was filtered (Celite 
and the solvent was evaporated. Chromatography (EtOAc / petroleum ether 1:49) gave 30h 
(232 mg, 63%) as a yellow solid, with properties as above. 
1-Methoxy-5-nitro-3-(4-trifluoromethylphenyl)isoquinoline (30i). To 37 (300 mg, 1.1 
mmol) in a dry flask was added Pd2dba3 (97 mg, 110 mol), SPhos (99 mg, 210 mol), 4-tri-
fluoromethylphenylbenzeneboronic acid (403 mg, 2.1 mmol) and K3PO4 (675 mg, 3.2 mmol). 
Dry DMF (8.0 mL) was added and the mixture was stirred at 135°C for 16 h. The mixture 
was filtered through Celite and the solvent was evaporated. Chromatography (EtOAc / pet-
roleum ether 3:197) gave 30i (209 mg, 57%) as a yellow solid: mp 125-127°C; 1H NMR 
(CDCl3)  4.25 (3 H, s, Me), 7.58 (1 H, t, J = 7.9 Hz, 7-H), 7.72 (2 H, d, J = 8.2 Hz, Ph 3,5-
H2), 8.25 (2 H, d, J = 8.1 Hz, Ph 2,6-H2), 8.46 (1 H, dd, J = 7.8, 1.3 Hz, 6-H), 8.50 (1 H, s, 4-
H), 8.58 (1 H, dt, J = 8.2, 1.1 Hz, 8-H); 13C NMR (CDCl3) (HSQC / HMBC)  54.23 (Me), 
105.94 (4-C), 120.18 (4a-C), 125.11 (7-C), 125.57 (q, J = 3.6 Hz, Ph 3,5-C2), 126.42 (q, J = 
275.0 Hz, CF3), 127.20 (Ph 2,6-C2), 128.75 (6-C), 131.17 (8a-C), 131.20 (8-C), 141.79 (Ph 1-
C), 144.82 (5-C), 150.01 (3-C), 160.56 (1-C); 19F NMR (CDCl3)  -62.56 (s, CF3); MS m/z 
371.0601 (M + Na)+ (C17H11F3N2O3Na requires 371.0622), 349.0775 (M + H)+ 
(C17H12F3N2O3 requires 349.0780). 
3-(4-Fluorophenyl)-1-methoxy-5-nitroisoquinoline (30j). To 37 (200 mg, 710 mol) in a 
dry flask was added Pd2dba3 (65 mg, 70 mol), SPhos (66 mg, 140 mol), 4-fluorobenzene-
boronic acid (148 mg, 1.1 mmol) and K3PO4 (448 mg, 2.1 mmol). Dry DMF (6.0 mL) was 
added and the mixture was stirred at 135°C for 16 h. The evaporation residue, in CHCl3, was 
filtered through Celite. Chromatography (EtOAc / petroleum ether 1:99 → 1:49) gave 30j 
(60 mg, 28%) as a yellow solid: mp 199-200°C; 1H NMR (CDCl3) 4.27 (3 H, s, Me), 7.19 
(2 H, t, J = 8.5 Hz, Ph 3,5-H2), 7.57 (1 H, t, J = 8.0 Hz, 7-H), 8.19 (2 H, m, Ph 2,6-H2), 8.47 
(1 H, s, 4-H), 8.49 (1 H, dd, J = 8.0, 1.0 Hz, 6-H), 8.61 (1 H, d, J = 8.0 Hz; 13C NMR (CDCl3) 
(HSQC / HMBC)54.11 (Me), 104.79 (4-C), 115.68 (d, J = 21.5 Hz, Ph 3,5-C2), 119.91 (4a-
C), 124.53 (7-C), 128.72 (6-C), 128.97 (d, J = 8.3 Hz, Ph 2,6-C2), 131.26 (8-C), 131.56 (8a-
C), 134.81 (Ph 1-C), 144.91 (5-C), 150.93 (3-C), 160.58 (1-C), 163.75 (d, J = 248.3 Hz, Ph 
4-C); MS m/z 299.0808 (M + H)+ (C16H12FN2O3 requires 299.0834). 
3-(2-Chlorophenyl)-1-methoxy-5-nitroisoquinoline (30k). Method A. To 28 (102 mg, 0.43 
mmol) were added Pd2(dba)3 (13 mg, 14 mol), SPhos (22 mg, 54 mol), 2-chlorobenzene-
boronic acid (202 mg, 1.3 mmol) and K3PO4 (202 mg, 0.95 mmol). Degassed PhMe (3.0 mL) 
was added and the mixture was stirred at 100°C. After 4.5 h, further Pd2(dba)3 (33.5 mg, 40 
mol) and SPhos (20.5 mg, 40 mol) were added and the mixture was stirred at 100C for a 
further 11.5 h. The evaporation residue, in CHCl3, was filtered. Chromatography (EtOAc / 
petroleum ether 1:99) gave 30k (135 mg, 100%) as a yellow solid, with properties as below. 
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3-(2-Chlorophenyl)-1-methoxy-5-nitroisoquinoline (30k). Method B. To 37 (200 mg, 710 
mol) were added Pd2dba3 (65 mg, 70 mol), SPhos (66 mg, 140 mol), 2-chlorobenzene-
boronic acid (165 mg, 1.1 mmol) and K3PO4 (450 mg, 2.1 mmol). Dry DMF (7.5 mL) was 
added and the mixture was stirred at 135°C for 16 h. The solvent was evaporated. The 
residue, in CHCl3, was filtered through Celite. Chromatography (EtOAc / petroleum ether 
3:197 → 1:19) gave 30k (132 mg, 60%) as a yellow solid: mp 122-127°C; 1H NMR (CDCl3) 
4.21 (3 H, s, Me), 7.39 (1 H, t, J = 7.2 Hz, Ph 5-H), 7.40 (1 H, t, J = 7.0 Hz, Ph 4-H), 7.53 
(1 H, dd, J = 7.5, 1.5 Hz, Ph 6-H), 7.63 (1 H, t, J = 7.9 Hz, 7-H), 7.73 (1 H, dd, J = 7.8, 1.7 
Hz, Ph 3-H), 8.37 (1 H, s, 4-H), 8.49 (1 H, dd, J = 7.8, 1.3 Hz, 6-H), 8.65 (1 H, dt, J = 8.2, 
1.1 Hz, 8-H); 13C NMR (CDCl3) (HSQC / HMBC) 54.39(Me), 110.19 (4-C), 119.79 (8a-
C), 125.05 (7-C), 126.84 (Ph 4-C), 128.46 (6-C), 129.62 (Ph 5-C), 130.48 (Ph 6-C), 130.74 
(4a-C), 131.13 (8-C), 131.67 (Ph 3-C), 144.95 (5-C), 160.29 (1-C); MS m/z 315.0533 (M + 
H)+ (C16H1235ClN2O3 requires 315.0538). 
3-(3-Chlorophenyl)-1-methoxy-5-nitroisoquinoline (30l). Method A. To 28 (104 mg, 0.44 
mmol) in a dry flask was added Pd2(dba)3 (44.0 mg, 48 mol), SPhos (40.3 mg, 98 mol), 3-
chlorobenzeneboronic acid (198 mg, 1.3 mmol) and K3PO4 (180 mg, 0.85 mmol). Degassed 
toluene (3.0 mL) was added and the mixture was stirred at 100°C for 40 h. The evaporation 
residue, in CHCl3, was filtered. Chromatography (Et2O / petroleum ether 1: 99) gave 30l (46 
mg, 34%) as a yellow solid, with properties as below. 
3-(3-Chlorophenyl)-1-methoxy-5-nitroisoquinoline (30l). Method B. To 37 (200 mg, 710 
mol) were added Pd2dba3 (65 mg, 70 mol), SPhos (66 mg, 140 mol), 3-chlorobenzene-
boronic acid (166 mg, 1.1 mmol) and K3PO4 (450 mg, 2.1 mmol). Dry DMF (7.5 mL) was 
added and the mixture was stirred at 135°C for 16 h. The solvent was evaporated. The resi-
due, in CHCl3, was filtered through Celite. Chromatography (EtOAc / petroleum ether 3:197 
→ 1:19) gave 30l (116 mg, 52%) as a yellow solid: mp 134-141°C; 1H NMR (CDCl3) 4.18 
(3 H, s, Me),7.41 (2 H, m, Ph 5,6-H2), 7.58 (1 H, t, J = 8.0 Hz, 7-H), 8.03 (1 H, dt, J = 6.9, 
1.9 Hz, Ph 4-H), 8.18 (1 H, s, Ph 2-H), 8.47 (1 H, dd, J = 7.8, 1.2 Hz, 6-H), 8.48 (1 H, s, 4-
H), 8.60 (1 H, dt, J = 8.2, 1.1, 8-H); 13C NMR (CDCl3) (HSQC / HMBC) 54.29 (Me), 
105.53 (4-C), 120.18 (8a-C), 124.90 (7-C), 125.05 (Ph 4-C), 127.21 (Ph 2-C), 128.73 (6-C), 
129.24 (Ph 6-C), 129.93 (Ph 5-C), 131.26 (8-C), 131.33 (4a-C), 134.81 (Ph 3-C), 140.43 (3a-
C), 144.95 (5-C), 150.30 (3-C), 160.58 (1-C); MS m/z 315.0529 (M + H)+ (C16H1235ClN2O3 
requires 315.0538). 
3-(4-Chlorophenyl)-1-methoxy-5-nitroisoquinoline (30m). Degassed toluene (3.0 mL) was 
added to 37 (96 mg, 0.34 mmol), Pd2(dba)3 (31 mg, 34 mol), SPhos (31.5 mg, 68 mol), 4-
chlorobenzeneboronic acid (79.3 mg, 0.51 mmol) and K3PO4 (215 mg, 1.01 mmol). The 
mixture was stirred at 100°C for 16 h. The evaporation residue, in CHCl3, was filtered 
(Celite). Chromatography (EtOAc / petroleum ether 1:39) gave 30m (104 mg, 98%) as a 
yellow solid: mp 168-169°C; 1H NMR (CDCl3)  4.24 (3 H, s, Me), 7.46 (2 H, dd, J = 6.8, 
2.0 Hz, Ph 2,6-H2), 7.56 (1 H, t, J = 7.9 Hz, 7-H), 8.13 (2 H, dd, J = 6.8, 2.0 Hz, Ph 3,5-H2), 
8.46 (1 H, dd, J = 7.7, 1.2 Hz, 6-H), 8.47 (1 H, s, 4-H), 8.59 (1 H, dt, J = 8.2, 0.92 Hz, 8-H); 
13C NMR (CDCl3) (HSQC / HMBC)  54.15 (Me), 105.06 (4-C), 120.04 (4a-C), 124.66 (7-
C), 128.31 (Ph 3,5-C2), 128.65 (6-C), 128.87 (Ph 2,6-C2), 131.18 (8-C), 131.29 (8a-C), 
135.41 (Ph 4-C), 137.07 (3-C), 150.67 (5-C), 160.81 (1-C); MS m/z 315.0531 (M + H)+ 
(C16H1135ClN2O3 requires 315.0536). 
3-(2,6-Dichlorophenyl)-1-methoxy-5-nitroisoquinoline (30n). To 37 (240 mg, 850 mol) 
was added Pd2dba3 (78 mg, 85 mol), SPhos (79 mg, 170 mol), 2,6-dichlorobenzeneboronic 
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acid (243 mg, 1.3 mmol) and K3PO4 (541 mg, 2.5 mmol). Dry DMF (8.0 mL) was added and 
the mixture was stirred at 135°C for 16 h. Filtration (Celite), evaporation and chromato-
graphy (EtOAc / petroleum ether 1: 99) gave 30n (35 mg, 12%) as a yellow solid: mp 122-
124°C; 1H NMR (CDCl3)  4.17 (3 H, s, Me), 7.30 (1 H, t, J = 8.7 Hz, Ph 4-H), 7.44 (2 H, d, 
J = 8.5 Hz, Ph 3,5-H2), 7.66 (1 H, t, J = 8.1 Hz, 7-H), 8.08 (1 H, s, 4-H), 8.52 (1 H, dd, J = 
7.8, 1.3 Hz, 6-H), 8.67 (1 H, dt, J = 8.2, 1.1 Hz, 8-H); 13C NMR (CDCl3) (HSQC / HMBC)  
54.61 (Me), 111.16 (4-C), 120.08 (4a-C), 125.36 (7-C), 128.24 (Ph 3,5-C2), 128.56 (6-C), 
129.82 (Ph 4-C), 130.75 (8a-C), 131.32 (8-C), 134.86 (Ph 2,6-C2), 138.19 (Ph 1-C), 144.94 
(5-C), 149.95 (3-C), 160.73 (1-C); MS m/z 348.9740 (M - H)- (C16H1135Cl37ClN2O3 requires 
348.9961). 
3-(3-Cyanophenyl)-1-methoxy-5-nitroisoquinoline (30q). Method A. To 37 (152 mg, 0.64 
mmol) in a dry flask was added Pd2(dba)3 (58.3 mg, 64 mol), SPhos (60.8 mg, 0.15 mmol), 
3-cyanobenzeneboronic acid (147 mg, 1.3 mmol) and K3PO4 (270 mg, 1.3 mmol). Degassed 
toluene (4.5 mL) was added and the mixture was stirred at 100°C for 16 h. The evaporation 
residue, in CHCl3, was filtered. Chromatography (EtOAc / petroleum ether 1:40) gave 30q 
(15.6 mg, 8%) as a yellow solid, with properties as below. 
3-(3-Cyanophenyl)-1-methoxy-5-nitroisoquinoline (30q). Method B. To 37 (200 mg, 710 
mol) were added Pd2dba3 (65 mg, 70 mol), SPhos (66 mg, 140 mol), 3-cyanobenzene-
boronic acid (148 mg, 1.1 mmol) and K3PO4 (448 mg, 2.1 mmol). Dry DMF (6.0 mL) was 
added and the mixture was stirred at 135°C for 16 h. The solvent was evaporated. The 
residue, in CHCl3, was filtered through Celite. Chromatography (EtOAc / petroleum ether 
1:99 → 1:10) gave 30q (20 mg, 9%): mp 195-196C; 1H NMR (CDCl3)4.29 (3 H, s, 
Me),7.62 (1 H, t, J = 8.0 Hz, Ph 5-H),7.64 (1 H, t, J = 8.0 Hz, 7-H), 7.72 (1 H, dt, J = 7.8, 
1.3 Hz, Ph 6-H), 8.38 (1 H, dt, J = 8.2, 1.2 Hz, Ph 4-H), 8.52 (1 H, dd, J = 7.8, 1.3 Hz, 6-H), 
8.55 (1 H, s, 4-H), 8.56 (1 H, s, Ph 2-H), 8.65 (1 H, dt, J = 8.2, 1.1 Hz, 8-H); 13C NMR 
(CDCl3) (HSQC / HMBC) 54.44 (Me),105.90 (4-C), 113.31 (Ph 1-C), 121.03 (4a-C), 
125.39 (7-C), 128.88 (6-C), 129.55 (Ph 2,5-C2), 130.98 (Ph 6-C), 131.30 (8-C), 132.45 (Ph 4-
C), 140.32 (CN), 145.67 (5-C), 160.92 (1-C). 
3-(4-Cyanophenyl)-1-methoxy-5-nitroisoquinoline (30r). To 28 (151 mg, 630 mol) were 
added Pd2dba3 (58 mg, 63 mol), SPhos (58 mg, 140 mol), 4-cyanobenzeneboronic acid 
(150 mg, 1.3 mmol) and K3PO4 (279 mg, 1.3 mmol). Degassed PhMe (4.5 mL) was added 
and the mixture was stirred at 100°C for 16 h. The evaporation residue, in CHCl3, was 
filtered. Chromatography (EtOAc / petroleum ether 1:99) gave 30r (53 mg, 28%) as a yellow 
solid: mp 206-210C; 1H NMR (CDCl3) 4.30 (3 H, s, Me), t, J = 8.0 Hz, 7-H), 
7.81 (2 H, d, J = 8.6 Hz, Ph 2,6-H2), 8.32 (2 H, d, J = 8.6 Hz, Ph 3,5-H2), 8.53 (1 H, dd, J = 
7.8, 1.2 Hz, 6-H), 8.59 (1 H, s, 4-H), 8.66 (1 H, d, J = 8.2 Hz, 8-H); 13C NMR (CDCl3) 
(HSQC / HMBC) 54.36 (Me),106.64 (4-C), 112.68 (CN), 118.79 (Ph 4-C), 120.80 (8a-C), 
125.56 (7-C), 127.58 (Ph 2,6-H2), 128.85 (6-C), 129.67 (4a-C), 131.26 (8-C), 132.53 (Ph 3,5-
H2), 142.86 (3-C), 145.16 (5-C), 149.59 (Ph 1-C), 160.84 (1-C). 
5-Amino-1-methoxy-3-(3-methoxyphenyl)isoquinoline (31e). Compound 30e (40 mg, 140 
mol) was stirred vigorously with Pd/C (10%, 44 mg) in EtOH (9 mL) under H2 for 5 h. Filt-
ration (Celite) and evaporation yielded 31e (31 mg, 81%) as a pale yellow solid: mp 146-
149C; 1H NMR (CDCl3)  3.91 (3 H, s, Ph OMe), 4.21 (3 H, s, 1-OMe), 6.93 (2 H, m, Ph 6-
H + 6-H), 7.31 (1 H, t, J = 7.8 Hz, 7-H), 7.39 (1 H, t, J = 8.0 Hz, Ph 5-H), 7.60 (1 H, s, 4-H), 
7.71 (3 H, m, Ph 2,4-H2 + 8-H); 13C NMR (CDCl3) (HSQC / HMBC)  53.60 (1-OMe), 55.31 
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(Ph-OMe), 104.17 (4-C), 112.39 (Ph 2-C), 113.47 (Ph 6-C), 114.05 (6-C), 114.47 (8-C), 
118.94 (Ph 4-C), 119.57 (8a-C), 126.75 (7-C), 128.36 (4a-C), 129.54 (Ph 5-C), 141.22 (Ph 1-
C), 141.58 (5-C), 146.53 (3-C), 159.92 (Ph 3-C), 160.68 (1-C); MS m/z 303.1110 (M + Na)+ 
(C17H16N2NaO2 requires 303.1110), 281.1278 (M + H)+ (C17H17N2O2 requires 281.1290). 
5-Amino-1-methoxy-3-(2-trifluoromethylphenyl)isoquinoline (31g). Compound 30g (48 
mg, 140 mol) was stirred vigorously with Pt/C (1%, 53 mg) in EtOH (6.0 mL) under H2 for 
4 h. Filtration (Celite) and evaporation gave 31g (29 mg, 66%) as a yellow solid: mp 172-
174°C; 1H NMR (CDCl3) 4.13 (OMe), 6.96 (1 H, dd, J = 7.5, 0.5 Hz, 6-H), 7.28 (1 H, s, 4-
H), 7.37 (1 H, t, J = 7.5 Hz, 7-H), 7.51 (1 H, t, J = 7.5 Hz, Ph 5-H), 7.63 (2 H, m, Ph 4,6-H2), 
7.73 (1 H, d, J = 8.5 Hz, 8-H), 7.81 (1 H, d, J = 8.0 Hz, Ph 3-H); 13C NMR (CDCl3) (HSQC / 
HMBC)53.85 (Me), 108.10 (4-C), 114.03 (6-C), 114.32 (8-C), 119.34 (8a-C), 124.28 (q, J 
= 272 Hz, CF3), 126.69 (q, J = 5.1 Hz, Ph 3-C), 127.17 (7-C), 127.57 (4a-C), 127.81 (Ph 5-
C), 128.54 (q, J = 30.1 Hz, Ph 2-C), 131.41 (Ph 6-C), 131.90 (Ph 4-C), 140.55 (Ph 1-C), 
141.56 (5-C), 147.56 (3-C), 160.35 (1-C); MS m/z 341.0872 (M + Na)+ (C17H13F3N2NaO 
requires 341.0880). 
5-Amino-1-methoxy-3-(3-trifluoromethylphenyl)isoquinoline (31h). Compound 30h (152 
mg, 440 mol) was stirred vigorously with Pd/C (10%, 165 mg) in EtOH (8.0 mL) under H2 
for 5.5 h. Filtration (Celite) and evaporation gave 31h (120 mg, 87%) as a pale buff solid: 
mp 89-91°C; 1H NMR (CDCl3)  4.22 (3 H, s, Me), 6.94 (1 H, d, J = 7.4 Hz, 6-H), 7.33 (1 H, 
t, J = 7.8 Hz, 7-H), 7.55 (1 H, t, J = 7.7 Hz, Ph 5-H), 7.62 (2 H, m, 4-H + Ph 4-H), 7.70 (1 H, 
d, J = 8.2 Hz, 8-H), 8.32 (1 H, d, J = 7.6 Hz, Ph 6-H), 8.40 (1 H, s, Ph 2-H); 13C NMR 
(CDCl3) (HSQC / HMBC)  53.70 (Me), 104.50 (4-C), 114.37 (6-C), 114.57 (8-C), 119.87 
(4a-C), 123.23 (q, J = 3.9 Hz, Ph 2-C), 124.39 (q, J = 270.8 Hz, CF3), 124.63 (q, J = 3.9 Hz, 
Ph 4-C), 127.24 (7-C), 128.22 (8a-C), 129.00 (Ph 5-C), 129.66 (Ph 6-C), 130.95 (q, J = 31.8 
Hz, Ph 3-C), 140.44 (Ph 1-C), 141.75 (5-C), 145.16 (3-C), 160.97 (1-C); 19F NMR (CDCl3) 
 -62.50 (s, CF3); MS m/z 319.1048 (M + H)+ (C17H14F3N2O requires 319.1060). 
5-Amino-1-methoxy-3-(4-trifluoromethylphenyl)isoquinoline (31i). Compound 30i (151 
mg, 430 mol) was stirred vigorously with Pd/C (10%, 165 mg) in EtOH (8.0 mL) under H2 
for 5.5 h. Filtration (Celite) and evaporation gave 31i (120 mg, 87%) as a buff solid: mp 
141-142°C; 1H NMR (CDCl3)  4.21 (3 H, s, Me), 6.95 (1 H, dd, J = 7.5, 0.8 Hz, 6-H), 7.34 
(1 H, t, J = 7.7 Hz, 7-H), 7.65 (1 H, s, 4-H), 7.71 (3 H, m, 8-H + Ph 3,5-H2), 8.25 (2 H, d, J = 
8.2 Hz, Ph 2,6-H2); 13C NMR (CDCl3) (HSQC / HMBC)  53.70 (Me), 104.97 (4-C), 114.40 
(6-C), 114.58 (8-C), 119.96 (4a-C), 123.26 (q, J = 269.9 Hz, CF3), 125.48 (q, J = 3.9 Hz, Ph 
3,5-C2), 126.68 (Ph 2,6-C2), 127.37 (7-C), 128.16 (8a-C), 129.86 (q, J = 31.9 Hz, Ph 4-C), 
141.78 (5-C), 143.06 (Ph 1-C), 145.21 (3-C), 160.97 (1-C); 19F NMR (CDCl3)  -62.40 (s, 
CF3); MS m/z 317.0907 (M - H)- (C17H12F3N2O requires 317.0900). 
5-Amino-3-(4-fluorophenyl)-1-methoxyisoquinoline (31j). Compound 30j (108 mg, 360 
mol) was stirred vigorously with Pd/C (10%, 118 mg) in EtOH (8.0 mL) under H2 for 6 h. 
Filtration (Celite) and evaporation gave 31j (90 mg, 69%) as an off-white solid: mp 154-
155°C; 1H NMR (CDCl3)  4.21 (3 H, s, Me), 6.94 (1 H, dd, J = 7.5, 1.0 Hz, 6-H), 7.15 (2 H, 
m, Ph 3,5-H2), 7.31 (1 H, t, J = 7.5 Hz, 7-H), 7.54 (1 H, s, 4-H), 7.69 (1 H, dt, J = 8.2, 1.0 Hz, 
8-H), 8.13 (2 H, m, Ph 2,6-H2); 13C NMR (CDCl3) (HSQC / HMBC)  53.62 (Me), 103.64 (4-
C), 114.31 (6-C), 114.67 (8-C), 115.42 (d, J = 21.5 Hz, Ph 3,5-C2), 119.40 (4a-C), 126.72 (7-
C), 128.62 (d, J = 10.4 Hz, Ph 2,6-C2), 128.53 (8a-C), 135.85 (d, J = 3.3 Hz, Ph 1-C), 141.37 
(5-C), 145.98 (3-C), 160.82 (1-C), 163.04 (d, J = 246.0 Hz, Ph 4-C); MS m/z 269.1074 (M + 
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H)+ (C16H14FN2O requires 269.1092); 19F NMR (CDCl3)  -114.31 (m, F); MS m/z 267.0925 
(M - H)- (C16H12FN2O requires 267.0932). 
5-Amino-3-(2-chlorophenyl)-1-methoxyisoquinoline (31k). Compound 30k (75 mg, 240 
mol) was stirred vigorously with Pt/C (1%, 84 mg) in EtOH (6.0 mL) under H2 for 5 h. Filt-
ration (Celite) and evaporation gave 31k (70 mg, 100%) as a yellow solid: mp 102-103 °C; 
1H NMR (CDCl3) 4.18 (Me), 6.93 (1 H, dd, J = 7.5 Hz, 6-H), 7.35 (3 H, m, 7-H + Ph 4,5-
H2), 7.51 (1 H, dd, J = 8.0, 1.0 Hz, Ph 3-H), 7.56 (1 H, s, 4-H), 7.73 (1 H, d, J = 8.0 Hz, 8-H), 
7.76 (1 H, dd, J = 7.5, 1.5 Hz, Ph 6-H); 13C NMR (CDCl3) (HSQC / HMBC)53.78 (Me), 
109.13 (4-C), 113.89 (6-C), 114.14 (8-C), 119.29 (4a-C), 126.75 (Ph 4-C), 127.17 (7-C), 
127.59 (8a-C), 128.83 (Ph 5-C), 130.27 (Ph 3-C), 131.75 (Ph 6-C), 132.32 (Ph 1-C), 139.34 
(Ph 2-C), 141.65 (5-C), 145.86 (3-C), 160.57 (1-C); MS m/z 285.0803 (M + H)+ 
(C16H1435ClN2O requires 285.0796). 
5-Amino-3-(3-chlorophenyl)-1-methoxyisoquinoline (31l). Compound 30l (75 mg, 240 
mol) was stirred vigorously with Pt/C (1%, 84 mg) in EtOH (6.0 mL) under H2 for 5 h. Filt-
ration (Celite) and evaporation gave 31l (62 mg, 91%) as a yellow solid: mp 94-95°C; 1H 
NMR (CDCl3) 4.20 (Me), 6.93 (1 H, dd, J = 7.5, 0.5 Hz, 6-H), 7.33 (3 H, m, 7-H + Ph 5,6-
H2), 7.57 (1 H, s, 4-H), 7.69 (1 H, d, J = 8.5 Hz, 8-H), 8.01 (1 H, d, J = 7.5 Hz, Ph 3-H), 8.14 
(1 H, s, Ph 2-H); 13C NMR (CDCl3) (HSQC / HMBC) 53.69 (Me), 104.39 (4-C), 114.31 (6-
C), 114.53 (8-C), 119.72 (4a-C), 124.47 (Ph 4-C), 126.57 (Ph 2-C), 127.07 (7-C), 128.19 (8a-
C), 128.01 (Ph 5-C), 129.74 (Ph 6-C), 134.56 (Ph 3-C), 141.47 (5-C), 141.57 (Ph 1-C), 
145.18 (3-C), 160.78 (1-C); MS m/z 285.0793 (M + H)+ (C16H1435ClN2O requires 285.0796). 
5-Amino-3-(2,6-dichlorophenyl)-1-methoxyisoquinoline (31n). Compound 30n (30 mg, 90 
mol) was stirred vigorously with Pd/C (10%, 33 mg) in EtOH (5.0 mL) under H2 for 5 h. 
Filtration (Celite) and evaporation gave 31n (27 mg, 94%) as a pale orange solid: mp 103-
104°C; 1H NMR (CDCl3)  4.12 (3 H, s, Me), 6.95 (1 H, dd, J = 7.5, 1.0 Hz, 6-H), 7.19 (1 H, 
d, J = 0.9 Hz, 4-H), 7.25 (1 H, t, J = 8.6 Hz, Ph 4-H), 7.36 (1 H, t, J = 7.6 Hz, 7-H), 7.42 (2 
H, d, J = 8.3 Hz, Ph 3,5- H2), 7.74 (1 H, dt, J = 8.2, 1.0 Hz, 8-H); 13C NMR (CDCl3) (HSQC / 
HMBC)  54.02 (Me), 109.70 (4-C), 114.00 (6-C), 114.37 (8-C), 127.36 (7-C), 128.15 (Ph 
3,5-C2), 129.30 (Ph 4-C), 119.69 (4a-C), 127.62 (8a-C), 135.25 (Ph 2,6-C2), 138.92 (Ph 1-C), 
141.65 (5-C), 144.58 (3-C), 160.94 (1-C); MS m/z 321.0356 (M + H)+ (C16H1335Cl37ClN2O 
requires 321.0375), 319.0387 (M + H)+ (C16H1335Cl2N2O requires 319.0405). 
5-Amino-3-(4-hydroxyphenyl)-1-methoxyisoquinoline (31p). Compound 30p (65 mg, 220 
mol) was stirred vigorously with Pd/C (10%, 71.5 mg) in EtOH (5.0 mL) under H2 for 6 h. 
Filtration (Celite) and evaporation gave 31p (63 mg, 98%) as a yellow solid: mp >230°C; 
1H NMR (CD3OD) 4.17 (3 H, s, Me), 6.87 (2 H, d, J = 7.0 Hz, Ph 3,5-H2), 6.94 (1 H, d, J = 
7.0 Hz, 6-H), 7.22 (1 H, t, J = 8.0 Hz, 7-H), 7.53 (1 H, d, J = 8.5 Hz, 8-H), 7.81 (1 H, s, 4-H), 
8.07 (2 H, d, J = 7.0 Hz, Ph 2,6-H2); 13C NMR (CD3OD) (HSQC / HMBC)  53.84 (Me), 
104.35 (4-C), 114.14 (8-C), 114.63 (6-C), 116.24 (Ph 3,5-C2), 120.52 (4a-C), 127.40 (7-C), 
128.85 (Ph 2,6-C2), 130.19 (8a-C), 132.74 (Ph 1-C), 144.38 (5-C), 147.73 (3-C), 158.86 (Ph 
4-C), 161.74 (1-C); MS m/z 267.1123 (M + H)+ (C16H15N2O2 requires 267.1135). 
5-Amino-3-(3-cyanophenyl)-1-methoxyisoquinoline (31q). Compound 30q (34 mg, 110 
mol) was stirred vigorously with Pd/C (10%, 38 mg) in EtOH (5.0 mL) under H2 for 6.5 h. 
Filtration (Celite), evaporation and chromatography (ethyl acetate / petroleum ether 1:39 → 
1:4) gave 31q (11.2 mg, 37%) as a golden buff solid: mp 183-184°C; 1H NMR (CDCl3)  
4.22 (3 H, s, Me), 6.96 (1 H, dd, J = 7.5, 1.0 Hz, 6-H), 7.35 (1 H, t, J = 7.6 Hz, 7-H), 7.56 (1 
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H, t, J = 7.4 Hz, Ph 5-H), 7.62 (1 H, s, 4-H), 7.63 (1 H, dt, J = 7.9, 1.5 Hz, Ph 6-H), 7.70 (1 
H, dt, J = 8.2, 0.9 Hz, 8-H), 8.36 (1 H, dt, J = 7.9, 1.3 Hz, Ph 4-H), 8.46 (1 H, t, J = 1.3 Hz, 
Ph 2-H); 13C NMR (CDCl3) (HSQC / HMBC)  53.80 (Me), 104.72 (4-C), 112.74 (Ph 3-C), 
114.52 (6-C), 114.58 (8-C), 119.14 (CN), 120.03 (8a-C), 127.53 (7-C), 128.08 (4a-C), 129.31 
(Ph 5-C), 130.26 (Ph 2-C), 130.49 (Ph 4-C), 131.27 (Ph 6-C), 140.84 (Ph 1-C), 141.81 (5-C), 
144.22 (3-C), 161.09 (1-C); MS m/z 276.1128 (M + H)+ (C17H14N3O requires 276.1137). 
5-Amino-3-(4-cyanophenyl)-1-methoxyisoquinoline (31r). Compound 30r (37 mg, 120 
mol) was stirred vigorously with Pd/C (10%, 41 mg) in EtOH (5.5 mL) under H2 for 6.5 h. 
Filtration (Celite), evaporation and chromatography (EtOAc / petroleum ether 1:39 → 1:4) 
gave 31r (17.3 mg, 52%) as an amber-coloured solid: mp 203-204°C; 1H NMR (CDCl3)  
4.21 (3 H, s, Me), 6.96 (1 H, dd, J = 7.6, 1.0 Hz, 6-H), 7.36 (1 H, t , J = 7.6 Hz, 7-H), 7.67 (1 
H, s, 4-H), 7.70 (1 H, dt, J = 7.3, 0.9 Hz, 8-H), 7.74 (2 H, d, J = 8.7 Hz, Ph 3,5-H2), 8.25 (2 
H, d, J = 8.7 Hz, Ph 2,6-H2); 13C NMR (CDCl3) (HSQC / HMBC)  53.76 (Me), 105.55 (4-
C), 111.27 (Ph 4-C), 114.58 (6-C), 114.61 (8-C), 119.17 (CN), 120.18 (4a-C), 126.89 (Ph 
2,6-C2), 127.77 (7-C), 127.98 (8a-C), 132.39 (Ph 3,5-C2), 141.93 (5-C). 143.93 (Ph 1-C), 
144.45 (3-C), 161.04 (1-C); MS m/z 276.1124 (M + H)+ (C17H14N3O requires 276.1137). 
Isoquinoline-1,3-dione (33). 2-Carboxyphenylacetic acid 32 (20.0 g, 111 mmol) was heated 
with finely ground urea (7.33 g, 122 mmol) at 175-185C for 2 h. Cooling and recrystallisat-
ion (MeOH) gave 33 (12.0 g, 67%%) as an off-white solid: mp 220-222C (lit.3 mp 236-
238C); 1H NMR ((CD3)2SO)  4.09 (3 H, s, CH2), 7.44 (1 H, d, J = 7.6 Hz, 5-H), 7.51 (1 H, 
t, J = 7.6 Hz, 7-H), 7.70 (1 H, td, J = 7.6, 1.2 Hz, 6-H), 8.07 (1 H, dd, J = 7.8, 1.1 Hz, 8-H), 
11.36 (1 H, s, N-H); 13C NMR ((CD3)2SO) (HSQC / HMBC)  35.92 (4-C), 124.95 (8a-C), 
127.16 (7-C), 127.41 (8-C), 127.87 (5-C), 133.47 (6-C), 136.66 (4a-C), 165.34 (1-C), 170.99 
(3-C).  
1,3-Dibromoisoquinoline (34). Method A. PBr3 (10 mL) was added slowly to 33 (1.41 g, 
8.7 mmol) and the mixture was heated at reflux for 16 h. The evaporation residue was 
quenched (sat. aq. NaHCO3) and extracted thrice with CHCl3. Chromatography (EtOAc / pet-
roleum ether 3:17), followed by chromatography (EtOAc / petroleum ether 1:49) gave 34 
(358 mg, 14%) as white crystals: mp 148-150C (lit.4 mp 147-147.5°C); 1H NMR 
((CD3)2SO) 7.93 (1 H, td, J = 6.9, 1.3 Hz, 6-H), 8.00 (1 H, td, J = 6.9, 1.2 Hz, 7-H), 8.10 (1 
H, dt, J = 8.1, 0.6 Hz, 5-H), 8.27 (1 H, d, J = 8.4 Hz, 8-H), 8.38 (1 H, s, 4-H)C NMR 
((CD3)2SO) (HSQC / HMBC) 124.66 (4-C), 126.85 (5-C), 127.13 (8a-C), 127.68 (4a-C), 
127.89 (8-C), 130.69 (6-C), 132.69 (7-C), 138.74 (3-C), 143.18 (1-C). Further elution gave 
35 (66 mg, 4%) as white crystals: mp 61-63C (lit.4 mp 63-64C; 1H NMR ((CD3)2SO) 
(NOE) td, J = 8.0, 1.2 Hz, 6-H), 7.90 (1 H, dt, J = 8.3, 1.2 Hz, 7-H), 8.03 (1 H, d, 
J = 8.3 Hz, 5-H), 8.23 (1 H, d, J = 8.3 Hz, 8-H), 8.27 (1 H, s, 4-H), 9.24 (1 H, s, 1-H); C 
NMR ((CD3)2SO) (HSQC / HMBC) 123.53 (4-C), 125.76 (5-C), 127.25 (4a-C), 127.80 (8-
C), 128.13 (6-C), 131.68 (7-C), 135.19 (3-C), 137.46 (8a-C), 153.19 (1-C). 
1,3-Dibromoisoquinoline (34). Method B. Isoquinoline-1,3-dione 33 (3.00 g, 18.6 mmol) 
was heated under reflux with POBr3 (10.7 g, 37 mmol) in 1,4-dioxane (20 mL) for 22 h. The 
mixture was quenched with MeOH, then water. The mixture, in water, was extracted thrice 
with CH2Cl2. Drying, evaporation and recrystallisation (PhMe) gave 34 (1.87 g, 35%) as an 
off-white solid, with properties as above. 
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4-Phenylethynylbenzonitrile (43). (Ph3P)2PdCl2 (96.5 mg, 140 mol), CuI (52 mg, 300 
mol), sodium ascorbate (33 mg, 160 mol) and 4-bromobenzonitrile 42 (500 mg, 2.75 
mmol) were mixed in a dry flask. Degassed THF (10 mL) and dry Pri2NH (5.0 mL) were 
added and the mixture was stirred at 50 °C for 30 min. Phenylethyne (281 mg, 2.75 mmol) 
was added and the mixture was stirred for 16 h at 50 °C. The mixture was filtered through 
Celite. Evaporation and chromatography (ethyl acetate / petroleum ether 1:199 → 1:99) 
gave 43 (394 mg, 70%) as an off-white solid: mp 78-79°C (lit.5 mp 91-92C); 1H NMR 
(CDCl3)  7.38 (3 H, m, Ph 3,4,5-H3), 7.55 (2 H, m, Ph 2,6-H2), 7.60 (4 H, m, NCPh 2,3,5,6-
H4); 13C NMR (CDCl3) (HSQC / HMBC)  87.66 (ethyne 1-C), 93.69 ((ethyne 2-C), 111.34 
(CN), 118.42 (NCPh 1-C), 122.11 (Ph 1-C), 128.11 (NCPh 4-C), 128.42 (Ph 3,5-C2), 129.04 
(Ph 4-C), 131.69 (Ph 2,6-C2), 131.93 (NCPh 2,6-C2), 131.95 (NCPh 3,5-C2). 
4-Dimethylaminomethylbenzonitrile (45a). 4-Bromomethylbenzonitrile (1.00 g, 5.1 mmol) 
was stirred with aq. Me2NH (40%, 4.0 mL) for 16 h. The mixture was diluted with water and 
extracted with CH2Cl2. The extract was washed with aqueous citric acid (10%). The com-
bined aqueous solutions were basified by addition of aq. NaOH (15%) and extracted with 
CH2Cl2. The combined solutions in CH2Cl2 were dried and the solvent was evaporated to 
give 45a (420 mg, 51%) as a colourless oil (lit.6 oil): 1H NMR (CDCl3)  2.24 (6 H, s, 
NMe2), 3.47 (2 H, s, CH2), 7.43 (2 H, d, J = 8.2 Hz, 3,5-H2), 7.61 (2 H, d, J = 8.2 Hz, 2,6-
H2); 13C NMR (CDCl3) (HSQC / HMBC)  45.42 (NMe2), 63.83 (CH2), 110.92 (1-C), 118.95 
(CN), 129.51 (3,5-C2), 132.13 (2,6-C2), 144.62 (4-C).  
4-(Piperidin-1-ylmethyl)benzonitrile (45b). 4-Bromomethylbenzonitrile (500 mg, 2.6 
mmol) was stirred with K2CO3 (388 mg, 2.8 mmol) and piperidine (238 mg, 2.8 mmol) in dry 
DMF (6.0 mL) at 20C for 3 h, then at 90°C for 3 d. The mixture was then cooled to 20C. 
Water (18 mL) was added and the mixture was stirred for 30 min. This mixture was diluted 
with EtOAc. The suspension was washed thrice with brine and dried. Evaporation of the sol-
vent gave 45b (340 mg, 67%) as a pale orange oil (lit.7 oil): 1H NMR (CDCl3)  1.44 (2 H, m, 
piperidine 4-H2), 1.57 (4 H, m, piperidine 3,5-H4), 2.36 (4 H, m, piperidine 2,6-H4), 3.50 (2 
H, s, PhCH2), 7.44 (2 H, d, J = 8.0 Hz, Ph 3,5-H2), 7.59 (2 H, d, J = 8.3 Hz, Ph 2,6-H2); 13C 
NMR (CDCl3) (HSQC / HMBC)  24.20 (piperidine 4-C), 25.94 (piperidine 3,5-C2), 54.60 
(piperidine 2,6-C2), 63.25 (PhCH2), 110.58 (Ph 1-C), 119.07 (CN), 129.46 (Ph 3,5-C2), 
131.99 (Ph 2,6-C2), 144.84 (Ph 4-C). 
4-(Pyrrolidin-1-ylmethyl)benzonitrile (45c). 4-Bromomethylbenzonitrile (1.00 g, 5.1 
mmol) in dry THF (15 mL) was stirred with Et3N (1.08 g, 10.7 mmol) and pyrrolidine (760 
mg, 10.7 mmol) for 2 d. This mixture was diluted with EtOAc, washed thrice with water and 
dried. Evaporation of the solvent gave 45c (935 mg, 98%) as a pale orange oil (lit.8 oil): 1H 
NMR (CDCl3)  1.79 (4 H, m, pyrrolidine 2,3-H4), 2.50 (4 H, m, pyrrolidine 1,4-H4), 3.65 (2 
H, s, PhCH2), 7.44 (2 H, d, J = 8.5 Hz, Ph 3,5-H2), 7.59 (2 H, d, J = 8.4 Hz, Ph 2,6-H2); 13C 
NMR (CDCl3) (HSQC / HMBC)  23.53 (pyrrolidine 2,3-C2), 54.24 (pyrrolidine 1,4-C2), 
60.23 (PhCH2), 110.67 (Ph 1-C), 119.05 (CN), 129.29 (Ph 3,5-C2), 132.10 (Ph 2,6-C2), 
145.29 (Ph 4-C).  
4-((4-Methylpiperazin-1-yl)methyl)benzonitrile (45d). 4-Bromomethylbenzonitrile (1.0 g, 
5.1 mmol) was stirred for 24 h with Et3N (1.03 g, 10.2 mmol) and 1-methylpiperazine (760 
mg, 7.6 mmol) in dry CH2Cl2 (10 mL). This mixture was diluted with CH2Cl2 and washed 
thrice with sat. aq. NaHCO3 and H2O. Drying and evaporation gave 45d (650 mg, 59%) as a 
white solid: mp 65-67°C (lit.9 mp 62-64C): 1H NMR (CDCl3)  2.29 (3 H, s, Me), 2.47 (8 H, 
m, piperazine 2,3,5,6-H8), 3.54 (2 H, s, PhCH2), 7.43 (2 H, d, J = 8.2 Hz, Ph 3,5-H2), 7.58 (2 
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H, d, J = 8.2 Hz, Ph 2,6-H2); 13C NMR (CDCl3) (HSQC / HMBC)  45.98 (Me), 53.08 
(piperazine 2,6-C2), 55.05 (piperazine 3,5-C2), 62.38 (PhCH2), 110.85 (Ph 1-C), 118.97 (CN), 
129.49 (Ph 3,5-C2), 132.10 (Ph 2,6-C2), 144.23 (Ph 4-C). 
Ferrocenenitrile (47). Ferrocenecarboxylic acid 46 (500 mg, 2.2 mmol) was stirred with 
oxalyl chloride (634 mg, 5.0 mmol) for 1 h. The evaporation residue, in dry THF (5.0 mL), 
was added dropwise to saturated NH3 in Et2O (25 mL). After 15 min, H2O (20 mL) was 
added and organic layer was washed thrice (H2O). Drying and evaporation gave ferrocene-
carboxamide (370 mg, 74%) as a pale orange solid: mp 168-169°C (lit.10 mp 168-171C); 1H 
NMR ((CD3)2SO)  4.15 (5 H, s, Fc’-H5), 4.32 (2 H, br, Fc 3,4-H2), 4.74 (2 H, br, Fc 2,5-H2), 
6.91 (1 H, br, NH), 7.28 (1 H, br, NH); 13C NMR ((CD3)2SO) (HSQC / HMBC)  68.49 (Fc 
2,5-C2), 69.31 (Fc’-C5), 69.91 (Fc 3,4-C2), 76.42 (Fc 1-C), 171.01 (C=O). This material (352 
mg, 1.5 mmol) was stirred with POCl3 (3.5 mL) at 120°C for 2 h, followed by cooling to 0°C 
and quench with H2O (1.0 mL). The mixture was diluted with EtOAc and washed thrice with 
H2O. Drying and evaporation gave 47 (360 mg, 99%) as a dark orange solid: mp 105-107°C 
(lit.11 mp 106-106.5C); 1H NMR ((CD3)2SO)  4.34 (5 H, s, Fc’-H5), 4.50 (2 H, s, Fc 3,4-
H2), 4.83 (2 H, s, Fc 2,5-H2); 13C NMR ((CD3)2SO) (HSQC / HMBC)  51.05 (Fc 1-C), 70.32 
(Fc’-C5), 71.00 (Fc 3,4-C2), 71.61 (Fc 2,5-C2), 120.21 (CN). 
3-Fluoro-2,N,N-trimethylbenzamide (49). SOCl2 (3.0 g, 25 mmol) was added to 48 (1.00 g, 
6.5 mmol) at 0°C. The mixture was heated at reflux for 16 h, then the excess SOCl2 was 
evaporated. The residue, in CH2Cl2 (1.0 mL), was added dropwise to a stirred solution of 
Me2NH in water (40 %, 3.7 mL) at 10°C. The mixture was then stirred at 20C for 2.5 h. The 
mixture was diluted with CH2Cl2, then washed thrice with water and dried. Evaporation gave 
49 (1.00 g, 85%) as a pale orange oil: 1H NMR (CDCl3)  2.19 (3 H, d, J = 2.0 Hz, 2-Me), 
2.82 (3 H, s, N-Me), 3.13 (3 H, s, N-Me), 6.96 (1 H, d, J = 7.6 Hz, 6-H), 7.01 (1 H, ddd, J = 
7.4, 6.1, 0.8 Hz, 4-H), 7.18 (1 H, m, 5-H); 13C NMR (CDCl3) (HSQC / HMBC)  11.20 (d, J 
= 4.5 Hz, 2-Me), 34.54 (N-Me), 38.28 (N-Me), 115.31 (d, J = 22.5 Hz, 4-C), 121.39 (d, J = 
3.6 Hz, 6-C), 121.59 (d, J = 18.3 Hz, 2-C), 127.45 (d, J = 8.6 Hz, 5-C), 138.90 (d, J = 3.9 Hz, 
1-C), 161.25 (d, J = 244.5 Hz, 3-C), 169.98 (d, J = 3.3 Hz, C=O); 19F NMR (CDCl3) 
 -115.66 (d, J = 6.1 Hz, 3-F); MS m/z (M + H)+ 182.0973 (C10H13FNO requires 182.0976). 
3-Methoxy-2,N,N-trimethylbenzamide (51). SOCl2 (2.74 g, 23 mmol) was added to 50 
(1.00 g, 6.0 mmol) at 0°C. The mixture was heated at reflux for 16 h, then the excess SOCl2 
was evaporated. The residue, in CH2Cl2 (3.0 mL), was added dropwise to a stirred solution of 
Me2NH in water (40 %, 3.7 mL) at 10°C. The mixture was then stirred at 20°C for 3.5 h. The 
mixture was diluted with CH2Cl2, then washed thrice with water and dried. The solvent was 
evaporated to give 51 (980 mg, 85%) as a pale yellow oil: 1H NMR (CDCl3)  2.12 (3 H, s, 2-
Me), 2.81 (3 H, s, N-Me), 3.12 (3 H, s, N-Me), 3.82 (3 H, s, OMe), 6.76 (1 H, dd, J = 7.6, 0.8 
Hz, 4-H), 6.81 (1 H, d, J = 8.2 Hz, 6-H), 7.18 (1 H, t, J = 7.6 Hz, 5-H); 13C NMR (CDCl3) 
(HSQC / HMBC)  12.42 (Me), 34.44 (N-Me), 38.24 (N-Me), 55.44 (OMe), 110.10 (6-C), 
117.73 (4-C), 122.69 (2-C), 126.97 (5-C), 137.99 (1-C), 157.76 (3-C), 171.23 (C=O); MS m/z 







Section C: Examples of graphs of enzyme activity vs. concentration for inhibition of 
tankyrase-2 by isoquinolin-1-ones. X-Axes – concentration of inhibitor (nM); Y-axes – 
optical density (490 nm).  






























































































































































































































Section D: Examples of graphs of enzyme activity vs. concentration for inhibition of 
tankyrase-1 by isoquinolin-1-ones. X-Axes – concentration of inhibitor (nM); Y-axes – 
optical density (490 nm).  





























































































Section E: Graphs of enzyme activity vs. concentration for inhibition of human PARP-2 






































Section F: Data from NCI 60-cell-line evaluations of selected isoquinolinones  






















































10 nM, 100 nM, 1.0 M, 10 M, 100 M 
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Section G: Crystal data for small-molecule X-ray crystallography 
 
Table 1. Crystal data and structure refinement for 13i. 
Identification code k12farm8 
 Empirical formula C34 H28 Cl4 N2 O3 
 Formula weight 654.38 
 Temperature 150(2) K 
 Wavelength 0.71073 Å 
 Crystal system Monoclinic 
 Space group P21/n 
 Unit cell dimensions a = 14.1190(3)Å  = 90 
    b = 13.6440(3)Å  = 96.302(1) 
    c = 15.7740(4)Å  = 90 
 Volume 3020.33(12) Å3 
 Z 4 
 Density (calculated) 1.439 Mg m-3 
 Absorption coefficient 0.431 mm-1 
 F(000) 1352 
 Crystal size 0.25  0.15  0.08 mm 
  range for data collection 3.62 to 26.37 
 Index ranges -17<=h<=17; -17<=k<=17; -19<=l<=19 
 Reflections collected 56157 
 Independent reflections 6157 [R(int) = 0.0932] 
 Reflections observed (>2) 4274 
 Data Completeness 0.997 
 Absorption correction Semi-empirical from equivalents 
 Max. and min. transmission 0.928 and 0.832 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 6157 / 0 / 391 
 Goodness-of-fit on F2 1.034 
 Final R indices [I>2(I)] R1 = 0.0502  wR2 = 0.1070 
 R indices (all data) R1 = 0.0868 wR2 = 0.1250 






Small crystal – poor diffraction at higher Bragg angles, hence data truncated at  = 26.4. Two 
molecules in the asymmetric unit plus one solvent entity (ethanol). Hydrogen-bonding present. 
Methyl hydrogen atoms attached to C16 and C16A are disordered. 
 
 
  D-H           d(D-H)   d(H..A)   <DHA    d(D..A)   A 
 
 O2-H2          0.840    1.988   174.03    2.825    O1A  
 
 N1-H1          0.880    1.947   170.53    2.819    O1A  
 




Table 2. Atomic coordinates ( 104) and equivalent isotropic  displacement parameters (Å2  103) for 1.U(eq) is 
defined as one third of the trace of the orthogonallised Uij tensor for 13i. 
  Atom   x   y   z  U(eq) 
Cl(1) 6739(1) 6508(1) 5251(1) 43(1) 
Cl(2) 6779(1) 3145(1) 7104(1) 35(1) 
O(1) 8901(1) 2703(1) 5088(1) 30(1) 
O(2) 6729(2) 3007(2) 3249(2) 51(1) 
N(1) 7908(2) 3810(2) 5586(1) 26(1) 
C(1) 6168(2) 5613(2) 5800(2) 31(1) 
C(2) 5211(2) 5739(2) 5874(2) 34(1) 
C(3) 4733(2) 5046(2) 6300(2) 38(1) 
C(4) 5216(2) 4233(2) 6660(2) 36(1) 
C(5) 6181(2) 4132(2) 6585(2) 29(1) 
C(6) 6690(2) 4804(2) 6142(2) 26(1) 
C(7) 7708(2) 4650(2) 6035(2) 25(1) 
C(8) 8425(2) 5243(2) 6344(2) 26(1) 
C(9) 9396(2) 5012(2) 6224(2) 24(1) 
C(10) 9587(2) 4125(2) 5812(2) 25(1) 
C(11) 8802(2) 3491(2) 5473(2) 26(1) 
C(12) 10522(2) 3860(2) 5709(2) 30(1) 
C(13) 11260(2) 4467(2) 6004(2) 33(1) 
C(14) 11076(2) 5357(2) 6393(2) 32(1) 
C(15) 10161(2) 5644(2) 6503(2) 26(1) 
C(16) 9966(2) 6627(2) 6895(2) 34(1) 
C(17) 7352(2) 2287(2) 2980(2) 47(1) 
C(18) 7566(3) 2559(3) 2092(2) 51(1) 
Cl(1A) 8342(1) -1484(1) 5145(1) 38(1) 
Cl(2A) 8970(1) 1794(1) 7072(1) 38(1) 
O(1A) 6463(1) 2497(1) 4942(1) 29(1) 
N(1A) 7483(2) 1314(2) 5481(1) 25(1) 
C(1A) 9101(2) -663(2) 5728(2) 26(1) 
C(2A) 10060(2) -884(2) 5836(2) 30(1) 
C(3A) 10687(2) -241(2) 6291(2) 34(1) 
C(4A) 10352(2) 597(2) 6654(2) 33(1) 
C(5A) 9385(2) 789(2) 6545(2) 28(1) 
C(6A) 8723(2) 187(2) 6066(2) 25(1) 
C(7A) 7699(2) 449(2) 5932(2) 25(1) 
C(8A) 6993(2) -75(2) 6225(2) 25(1) 
C(9A) 6024(2) 259(2) 6099(2) 24(1) 
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C(10A) 5826(2) 1162(2) 5674(2) 24(1) 
C(11A) 6594(2) 1704(2) 5340(2) 25(1) 
C(12A) 4902(2) 1535(2) 5562(2) 29(1) 
C(13A) 4173(2) 1015(2) 5849(2) 31(1) 
C(14A) 4353(2) 114(2) 6253(2) 32(1) 
C(15A) 5261(2) -279(2) 6385(2) 27(1) 




Table 3. Bond lengths [Å] and angles [] for 13i. 
Cl(1)-C(1) 1.745(3) Cl(2)-C(5) 1.744(3) 
O(1)-C(11) 1.250(3) O(2)-C(17) 1.414(4) 
N(1)-C(11) 1.366(3 N(1)-C(7) 1.392(3) 
C(1)-C(2) 1.380(4) C(1)-C(6) 1.402(4) 
C(2)-C(3) 1.378(4) C(3)-C(4) 1.391(4) 
C(4)-C(5) 1.388(4) C(5)-C(6) 1.398(4) 
C(6)-C(7) 1.481(4) C(7)-C(8) 1.345(4) 
C(8)-C(9) 1.439(4)  C(9)-C(10) 1.414(4) 
C(9)-C(15) 1.414(4)  C(10)-C(12) 1.396(4) 
C(10)-C(11) 1.461(4) C(12)-C(13) 1.371(4) 
C(13)-C(14) 1.398(4) C(14)-C(15) 1.379(4) 
C(15)-C(16) 1.514(4) C(17)-C(18) 1.511(5) 
Cl(1A)-C(1A) 1.741(3) Cl(2A)-C(5A) 1.737(3) 
O(1A)-C(11A) 1.254(3) N(1A)-C(11A) 1.360(3) 
N(1A)-C(7A) 1.394(3) C(1A)-C(2A) 1.381(4) 
C(1A)-C(6A) 1.405(4) C(2A)-C(3A) 1.388(4) 
C(3A)-C(4A) 1.384(4) C(4A)-C(5A) 1.384(4) 
C(5A)-C(6A) 1.401(4) C(6A)-C(7A) 1.482(4) 
C(7A)-C(8A) 1.349(4) C(8A)-C(9A) 1.435(4) 
C(9A)-C(15A) 1.417(4) C(9A)-C(10A) 1.416(4) 
C(10A)-C(12A) 1.394(4) C(10A)-C(11A) 1.457(4) 
C(12A)-C(13A) 1.367(4) C(13A)-C(14A) 1.394(4) 
C(14A)-C(15A) 1.385(4) C(15A)-C(16A) 1.506(4) 
C(11)-N(1)-C(7) 124.8(2) C(2)-C(1)-C(6) 122.9(3) 
C(2)-C(1)-Cl(1) 117.7(2) C(6)-C(1)-Cl(1) 119.4(2) 
C(3)-C(2)-C(1) 119.5(3) C(2)-C(3)-C(4) 120.1(3) 
C(5)-C(4)-C(3) 119.1(3) C(4)-C(5)-C(6) 122.7(3) 
C(4)-C(5)-Cl(2) 117.7(2) C(6)-C(5)-Cl(2) 119.5(2) 
C(5)-C(6)-C(1) 115.6(3) C(5)-C(6)-C(7) 121.5(2) 
C(1)-C(6)-C(7) 122.9(2) C(8)-C(7)-N(1) 119.6(2) 
C(8)-C(7)-C(6) 125.0(2) N(1)-C(7)-C(6) 115.3(2) 
C(7)-C(8)-C(9) 120.6(2) C(10)-C(9)-C(15) 119.1(2) 
C(10)-C(9)-C(8) 118.8(2) C(15)-C(9)-C(8) 122.1(2) 
C(12)-C(10)-C(9) 120.5(3) C(12)-C(10)-C(11) 119.6(2) 
C(9)-C(10)-C(11) 119.9(2) O(1)-C(11)-N(1) 119.5(2) 
O(1)-C(11)-C(10) 124.5(2) N(1)-C(11)-C(10) 116.0(2) 
C(13)-C(12)-C(10) 119.8(3) C(12)-C(13)-C(14) 120.2(3) 
C(15)-C(14)-C(13) 121.6(3) C(14)-C(15)-C(9) 118.8(2) 
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C(14)-C(15)-C(16) 121.2(3) C(9)-C(15)-C(16) 120.0(2) 
O(2)-C(17)-C(18) 107.6(3) C(11A)-N(1A)-C(7A) 124.1(2) 
C(2A)-C(1A)-C(6A) 122.8(3) C(2A)-C(1A)-Cl(1A) 117.6(2) 
C(6A)-C(1A)-Cl(1A) 119.6(2) C(1A)-C(2A)-C(3A) 119.1(3) 
C(4A)-C(3A)-C(2A) 120.6(3) C(3A)-C(4A)-C(5A) 118.8(3) 
C(4A)-C(5A)-C(6A) 123.1(3) C(4A)-C(5A)-Cl(2A) 118.0(2) 
C(6A)-C(5A)-Cl(2A) 118.8(2) C(5A)-C(6A)-C(1A) 115.5(2) 
C(5A)-C(6A)-C(7A) 121.2(2) C(1A)-C(6A)-C(7A) 123.4(2) 
C(8A)-C(7A)-N(1A) 119.7(2) C(8A)-C(7A)-C(6A) 124.7(2) 
N(1A)-C(7A)-C(6A) 115.6(2) C(7A)-C(8A)-C(9A) 121.0(2) 
C(15A)-C(9A)-C(10A) 119.0(2) C(15A)-C(9A)-C(8A) 122.6(2) 
C(10A)-C(9A)-C(8A) 118.5(2) C(12A)-C(10A)-C(9A) 120.7(3) 
C(12A)-C(10A)-C(11A) 119.4(2) C(9A)-C(10A)-C(11A) 119.8(2) 
O(1A)-C(11A)-N(1A) 120.2(2) O(1A)-C(11A)-C(10A) 123.0(2) 
N(1A)-C(11A)-C(10A) 116.9(2) C(13A)-C(12A)-C(10A) 119.7(3) 
C(12A)-C(13A)-C(14A) 120.2(3) C(15A)-C(14A)-C(13A) 122.0(3) 
C(14A)-C(15A)-C(9A) 118.4(3) C(14A)-C(15A)-C(16A) 120.6(3) 




Table 4. Anisotropic displacement parameters (Å2  103) for 13i. The anisotropic displacement factor exponent 
takes the form: -2 gpi2 [ h2 a*2 U11 + ... + 2 h k a* b* U 
  Atom  U11  U22  U33  U23  U13  U12 
Cl(1) 36(1) 30(1) 64(1) 15(1) 9(1) 7(1) 
Cl(2) 43(1) 27(1) 34(1) 4(1) 7(1) -2(1) 
O(1) 36(1) 20(1) 34(1) -4(1) 9(1) 2(1) 
O(2) 54(2) 55(2) 44(2) 11(1) 14(1) 15(1) 
N(1) 28(1) 19(1) 32(1) -1(1) 4(1) 1(1) 
C(1) 34(2) 25(2) 33(2) -2(1) 4(1) 0(1) 
C(2) 30(2) 35(2) 39(2) -5(1) 4(1) 6(1) 
C(3) 28(2) 47(2) 40(2) -9(2) 7(1) 2(1) 
C(4) 36(2) 39(2) 36(2) -6(1) 9(1) -9(1) 
C(5) 33(2) 24(1) 30(2) -6(1) 3(1) -1(1) 
C(6) 28(2) 20(1) 29(1) -5(1) 6(1) 0(1) 
C(7) 30(2) 19(1) 26(1) 2(1) 6(1) 3(1) 
C(8) 31(2) 20(1) 28(1) 0(1) 4(1) 3(1) 
C(9) 28(1) 22(1) 23(1) 4(1) 4(1) 2(1) 
C(10) 31(2) 21(1) 24(1) 4(1) 4(1) 1(1) 
C(11) 31(2) 20(1) 26(1) 5(1) 5(1) 5(1) 
C(12) 33(2) 28(2) 30(2) 2(1) 8(1) 7(1) 
C(13) 27(2) 37(2) 35(2) 3(1) 7(1) 5(1) 
C(14) 33(2) 33(2) 29(2) 2(1) 1(1) -2(1) 
C(15) 30(2) 25(1) 24(1) 3(1) 1(1) 2(1) 
C(16) 32(2) 27(2) 41(2) -3(1) 0(1) -3(1) 
C(17) 40(2) 40(2) 61(2) 4(2) 10(2) -1(2) 
C(18) 50(2) 61(2) 44(2) -9(2) 10(2) -11(2) 
Cl(1A) 35(1) 27(1) 53(1) -13(1) 1(1) 1(1) 
Cl(2A) 50(1) 25(1) 35(1) -7(1) -3(1) 5(1) 
O(1A) 34(1) 20(1) 32(1) 6(1) 2(1) 4(1) 
N(1A) 28(1) 19(1) 28(1) 2(1) 4(1) 3(1) 
C(1A) 30(2) 20(1) 29(2) 1(1) 2(1) 0(1) 
C(2A) 35(2) 22(1) 34(2) 2(1) 7(1) 7(1) 
C(3A) 30(2) 35(2) 37(2) 8(1) 2(1) 3(1) 
C(4A) 35(2) 30(2) 33(2) 1(1) -2(1) -5(1) 
C(5A) 34(2) 20(1) 28(2) 3(1) 2(1) 2(1) 
C(6A) 30(2) 22(1) 24(1) 3(1) 2(1) 2(1) 
C(7A) 32(2) 18(1) 23(1) -2(1) 2(1) 3(1) 
C(8A) 32(2) 17(1) 27(1) 1(1) 3(1) 4(1) 
C(9A) 29(2) 21(1) 22(1) -3(1) 4(1) 0(1) 
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C(10A) 30(2) 21(1) 22(1) -4(1) 4(1) 2(1) 
C(11A) 32(2) 21(1) 21(1) -3(1) 0(1) 3(1) 
C(12A) 30(2) 29(2) 27(1) -3(1) -1(1) 6(1) 
C(13A) 26(2) 34(2) 33(2) -4(1) 2(1) 4(1) 
C(14A) 31(2) 36(2) 29(2) -5(1) 5(1) -6(1) 
C(15A) 32(2) 23(1) 26(1) -4(1) 2(1) 1(1) 





Table 5. Hydrogen coordinates ( 104) and isotropic displacement parameters (Å2  103) for 13i. 
  Atom   x   y   z  U(eq) 
H(2) 6631 2896 3756 104(19) 
H(1) 7422 3459 5359 31 
H(2B) 4883 6299 5633 41 
H(3) 4072 5124 6347 46 
H(4) 4890 3753 6953 44 
H(8) 8289 5821 6646 32 
H(12) 10648 3260 5436 36 
H(13) 11897 4282 5943 39 
H(14) 11594 5774 6586 38 
H(16A) 9279 6701 6921 50 
H(16B) 10192 7153 6544 50 
H(16C) 10301 6663 7472 50 
H(16D) 10568 6977 7037 50 
H(16E) 9656 6525 7414 50 
H(16F) 9547 7015 6486 50 
H(17A) 7049 1633 2975 56 
H(17B) 7949 2267 3373 56 
H(18A) 6976 2542 1702 77 
H(18B) 8024 2092 1899 77 
H(18C) 7837 3221 2099 77 
H(1A) 7952 1627 5276 30 
H(2A) 10290 -1468 5602 36 
H(3A) 11350 -377 6354 41 
H(4A) 10780 1032 6972 40 
H(8A) 7139 -673 6519 30 
H(12A) 4779 2148 5287 35 
H(13A) 3543 1267 5772 38 
H(14A) 3837 -239 6443 38 
H(16G) 6106 -1427 6845 53 
H(16H) 5059 -1765 6464 53 
H(16I) 5220 -1245 7378 53 
H(16J) 4818 -1530 6946 53 
H(16K) 5864 -1193 7327 53 





Table 6. Dihedral angles [] for 13i. 
  Atom1  -  Atom2  -  Atom3  -  Atom4  Dihedral 
C(6) - C(1) - C(2) - C(3) -0.1(4) 
Cl(1) - C(1) - C(2) - C(3) 179.8(2) 
C(1) - C(2) - C(3) - C(4) 0.7(4) 
C(2) - C(3) - C(4) - C(5) 0.1(4) 
C(3) - C(4) - C(5) - C(6) -1.6(4) 
C(3) - C(4) - C(5) - Cl(2) 175.9(2) 
C(4) - C(5) - C(6) - C(1) 2.1(4) 
Cl(2) - C(5) - C(6) - C(1) -175.4(2) 
C(4) - C(5) - C(6) - C(7) -176.8(3) 
Cl(2) - C(5) - C(6) - C(7) 5.8(4) 
C(2) - C(1) - C(6) - C(5) -1.2(4) 
Cl(1) - C(1) - C(6) - C(5) 178.9(2) 
C(2) - C(1) - C(6) - C(7) 177.6(3) 
Cl(1) - C(1) - C(6) - C(7) -2.3(4) 
C(11) - N(1) - C(7) - C(8) 4.3(4) 
C(11) - N(1) - C(7) - C(6) -174.6(2) 
C(5) - C(6) - C(7) - C(8) -117.3(3) 
C(1) - C(6) - C(7) - C(8) 63.9(4) 
C(5) - C(6) - C(7) - N(1) 61.6(3) 
C(1) - C(6) - C(7) - N(1) -117.2(3) 
N(1) - C(7) - C(8) - C(9) -0.7(4) 
C(6) - C(7) - C(8) - C(9) 178.2(2) 
C(7) - C(8) - C(9) - C(10) -3.1(4) 
C(7) - C(8) - C(9) - C(15) 176.7(2) 
C(15) - C(9) - C(10) - C(12) 2.4(4) 
C(8) - C(9) - C(10) - C(12) -177.8(2) 
C(15) - C(9) - C(10) - C(11) -176.3(2) 
C(8) - C(9) - C(10) - C(11) 3.5(4) 
C(7) - N(1) - C(11) - O(1) 177.1(2) 
C(7) - N(1) - C(11) - C(10) -3.8(4) 
C(12) - C(10) - C(11) - O(1) 0.2(4) 
C(9) - C(10) - C(11) - O(1) 178.9(2) 
C(12) - C(10) - C(11) - N(1) -178.9(2) 
C(9) - C(10) - C(11) - N(1) -0.3(4) 
C(9) - C(10) - C(12) - C(13) -0.6(4) 
C(11) - C(10) - C(12) - C(13) 178.1(2) 
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C(10) - C(12) - C(13) - C(14) -1.1(4) 
C(12) - C(13) - C(14) - C(15) 1.0(4) 
C(13) - C(14) - C(15) - C(9) 0.9(4) 
C(13) - C(14) - C(15) - C(16) -177.6(3) 
C(10) - C(9) - C(15) - C(14) -2.5(4) 
C(8) - C(9) - C(15) - C(14) 177.7(2) 
C(10) - C(9) - C(15) - C(16) 176.0(2) 
C(8) - C(9) - C(15) - C(16) -3.8(4) 
C(6A) - C(1A) - C(2A) - C(3A) -0.4(4) 
Cl(1A) - C(1A) - C(2A) - C(3A) 179.4(2) 
C(1A) - C(2A) - C(3A) - C(4A) 1.8(4) 
C(2A) - C(3A) - C(4A) - C(5A) -0.9(4) 
C(3A) - C(4A) - C(5A) - C(6A) -1.4(4) 
C(3A) - C(4A) - C(5A) - Cl(2A) 175.2(2) 
C(4A) - C(5A) - C(6A) - C(1A) 2.7(4) 
Cl(2A) - C(5A) - C(6A) - C(1A) -173.95(19) 
C(4A) - C(5A) - C(6A) - C(7A) -177.0(3) 
Cl(2A) - C(5A) - C(6A) - C(7A) 6.4(3) 
C(2A) - C(1A) - C(6A) - C(5A) -1.7(4) 
Cl(1A) - C(1A) - C(6A) - C(5A) 178.4(2) 
C(2A) - C(1A) - C(6A) - C(7A) 177.9(3) 
Cl(1A) - C(1A) - C(6A) - C(7A) -1.9(4) 
C(11A) - N(1A) - C(7A) - C(8A) 2.9(4) 
C(11A) - N(1A) - C(7A) - C(6A) -175.9(2) 
C(5A) - C(6A) - C(7A) - C(8A) -115.8(3) 
C(1A) - C(6A) - C(7A) - C(8A) 64.6(4) 
C(5A) - C(6A) - C(7A) - N(1A) 63.0(3) 
C(1A) - C(6A) - C(7A) - N(1A) -116.7(3) 
N(1A) - C(7A) - C(8A) - C(9A) -1.7(4) 
C(6A) - C(7A) - C(8A) - C(9A) 177.0(2) 
C(7A) - C(8A) - C(9A) - C(15A) 178.9(2) 
C(7A) - C(8A) - C(9A) - C(10A) -1.2(4) 
C(15A) - C(9A) - C(10A) - C(12A) 2.1(4) 
C(8A) - C(9A) - C(10A) - C(12A) -177.8(2) 
C(15A) - C(9A) - C(10A) - C(11A) -177.0(2) 
C(8A) - C(9A) - C(10A) - C(11A) 3.0(4) 
C(7A) - N(1A) - C(11A) - O(1A) 178.5(2) 
C(7A) - N(1A) - C(11A) - C(10A) -1.0(4) 
C(12A) - C(10A) - C(11A) - O(1A) -0.7(4) 
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C(9A) - C(10A) - C(11A) - O(1A) 178.5(2) 
C(12A) - C(10A) - C(11A) - N(1A) 178.9(2) 
C(9A) - C(10A) - C(11A) - N(1A) -1.9(4) 
C(9A) - C(10A) - C(12A) - C(13A) -1.4(4) 
C(11A) - C(10A) - C(12A) - C(13A) 177.8(2) 
C(10A) - C(12A) - C(13A) - C(14A) 0.0(4) 
C(12A) - C(13A) - C(14A) - C(15A) 0.5(4) 
C(13A) - C(14A) - C(15A) - C(9A) 0.2(4) 
C(13A) - C(14A) - C(15A) - C(16A) -178.5(3) 
C(10A) - C(9A) - C(15A) - C(14A) -1.5(4) 
C(8A) - C(9A) - C(15A) - C(14A) 178.4(2) 
C(10A) - C(9A) - C(15A) - C(16A) 177.2(2) 





Table 7. Crystal data and structure refinement for 15b. 
Identification code k12farm10 
 Formula weight 265.30 
 Temperature 150(2) K 
 Wavelength 0.71073 Å 
 Crystal system Monoclinic 
 Space group P21/n 
 Unit cell dimensions a = 12.5690(8)Å  = 90 
       b = 17.0250(11)Å  = 104.837(2) 
       c = 13.3300(11)Å  = 90 
 Volume 2757.3(3) Å3 
 Z 8 
 Density (calculated) 1.278 Mg m-3 
 Absorption coefficient 0.084 mm-1 
 F(000) 1120 
 Crystal size 0.30  0.08  0.08 mm 
  range for data collection 3.52 to 25.03 
 Index ranges -14<=h<=14; -20<=k<=20; -11<=l<=15 
 Reflections collected 12394 
 Independent reflections 4788 [R(int) = 0.1450] 
 Reflections observed (>2) 1941 
 Data Completeness 0.982 
 Absorption correction Semi-empirical from equivalents 
 Max. and min. transmission 1.000 and 0.710 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 4788 / 0 / 365 
 Goodness-of-fit on F2 0.895 
 Final R indices [I>2(I)] R1 = 0.0717  wR2 = 0.1299 
 R indices (all data) R1 = 0.2113 wR2 = 0.1699 





Two independent molecules in the asymmetric unit, which form hydrogen-bonded dimers. 
 
Crystal quality poor - small fragment taken from a non-merohedrally twinned needle. Unit cell 
parameters reflect the sample quality. However, the structure is unambiguous. Data truncated to 25 
degree Bragg angle. 
 
 
Hydrogen bonds with  H..A < r(A) + 2.000 Angstroms  and  <DHA > 110 deg. 
 
 D-H           d(D-H)   d(H..A)   <DHA    d(D..A)   A 
 
 N1-H1          0.880    1.917   168.55    2.785    O1A  
 





Table 8. Atomic coordinates ( 104) and equivalent isotropic displacement parameters (Å2  103) for 1.U(eq) is 
defined as one third of the trace of the orthogonallised Uij tensor for 15b. 
 Atom  x  y  z  U(eq) 
O(1) 4518(2) 1373(1) -78(2) 50(1) 
O(2) 701(2) 3499(1) -299(3) 76(1) 
N(1) 3249(2) 1302(2) 854(2) 42(1) 
C(1) 3670(3) 1634(2) 109(3) 46(1) 
C(2) 3060(3) 2313(2) -435(3) 44(1) 
C(3) 3416(3) 2679(2) -1231(3) 53(1) 
C(4) 2872(3) 3325(2) -1706(4) 65(1) 
C(5) 1944(4) 3608(2) -1412(4) 72(1) 
C(6) 1590(3) 3260(2) -636(4) 62(1) 
C(7) 2139(3) 2589(2) -126(3) 48(1) 
C(8) 1785(3) 2199(2) 675(3) 53(1) 
C(9) 2328(3) 1560(2) 1161(3) 44(1) 
C(10) 2011(3) 1117(2) 1975(3) 48(1) 
C(11) 1408(3) 1453(2) 2609(4) 68(1) 
C(12) 1129(4) 1037(3) 3386(4) 83(2) 
C(13) 1447(4) 257(3) 3583(4) 71(1) 
C(14) 2019(3) -74(2) 2953(4) 69(1) 
C(15) 2300(3) 331(2) 2160(4) 59(1) 
C(16) 1147(4) -195(3) 4464(5) 117(2) 
C(17) 19(4) 4110(3) -875(4) 103(2) 
O(1A) 4580(2) 54(1) 1769(2) 59(1) 
O(2A) 8876(2) -1580(1) 3110(2) 68(1) 
N(1A) 6113(2) 279(2) 1218(2) 44(1) 
C(1A) 5547(3) -119(2) 1807(3) 45(1) 
C(2A) 6148(3) -725(2) 2490(3) 48(1) 
C(3A) 5629(3) -1157(2) 3129(3) 54(1) 
C(4A) 6200(3) -1722(2) 3751(4) 59(1) 
C(5A) 7298(3) -1886(2) 3788(3) 59(1) 
C(6A) 7818(3) -1469(2) 3165(3) 56(1) 
C(7A) 7252(3) -868(2) 2501(3) 43(1) 
C(8A) 7758(3) -417(2) 1841(3) 49(1) 
C(9A) 7206(3) 148(2) 1208(3) 40(1) 
C(10A) 7670(3) 638(2) 512(3) 42(1) 
C(11A) 8796(3) 628(2) 582(4) 63(1) 
C(12A) 9240(3) 1053(2) -91(4) 66(1) 
C(13A) 8608(3) 1518(2) -851(4) 58(1) 
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C(14A) 7495(3) 1542(2) -908(3) 56(1) 
C(15A) 7029(3) 1111(2) -254(3) 50(1) 
C(16A) 9095(3) 1960(2) -1614(4) 77(1) 





Table 9. Bond lengths [Å] and angles [] for 15b. 
O(1)-C(1) 1.238(4) O(2)-C(6) 1.369(4) 
O(2)-C(17) 1.438(5 N(1)-C(1) 1.360(4) 
N(1)-C(9) 1.395(4) C(1)-C(2) 1.472(5) 
C(2)-C(3) 1.399(5) C(2)-C(7) 1.405(4) 
C(3)-C(4) 1.364(5) C(4)-C(5) 1.406(5) 
C(5)-C(6) 1.363(5) C(6)-C(7) 1.416(5) 
C(7)-C(8) 1.423(5) C(8)-C(9) 1.357(5) 
C(9)-C(10) 1.459(5)  C(10)-C(15) 1.392(5) 
C(10)-C(11) 1.394(5) C(11)-C(12) 1.373(6) 
C(12)-C(13) 1.394(6) C(13)-C(14) 1.360(5) 
C(13)-C(16) 1.529(6) C(14)-C(15) 1.382(5) 
O(1A)-C(1A) 1.239(4) O(2A)-C(6A) 1.364(4) 
O(2A)-C(17A) 1.438(4 N(1A)-C(1A) 1.367(4) 
N(1A)-C(9A) 1.394(4) C(1A)-C(2A) 1.453(5) 
C(2A)-C(7A) 1.404(4) C(2A)-C(3A) 1.406(5) 
C(3A)-C(4A) 1.350(5) C(4A)-C(5A) 1.397(5) 
C(5A)-C(6A) 1.377(5) C(6A)-C(7A) 1.420(5) 
C(7A)-C(8A) 1.434(5) C(8A)-C(9A) 1.348(5) 
C(9A)-C(10A) 1.476(5)  C(10A)-C(15A) 1.385(5) 
C(10A)-C(11A) 1.395(5) C(11A)-C(12A) 1.377(5) 
C(12A)-C(13A) 1.369(6) C(13A)-C(14A) 1.382(5) 
C(13A)-C(16A) 1.514(5) C(14A)-C(15A) 1.380(5) 
C(6)-O(2)-C(17) 117.7(4) C(1)-N(1)-C(9) 126.2(3) 
O(1)-C(1)-N(1) 121.0(3) O(1)-C(1)-C(2) 123.2(4) 
N(1)-C(1)-C(2) 115.8(3) C(3)-C(2)-C(7) 121.4(3) 
C(3)-C(2)-C(1) 119.8(3) C(7)-C(2)-C(1) 118.8(4) 
C(4)-C(3)-C(2) 119.5(4) C(3)-C(4)-C(5) 120.0(4) 
C(6)-C(5)-C(4) 121.2(4) C(5)-C(6)-O(2) 125.0(4) 
C(5)-C(6)-C(7) 120.1(4) O(2)-C(6)-C(7) 114.9(4) 
C(2)-C(7)-C(6) 117.8(4) C(2)-C(7)-C(8) 120.3(3) 
C(6)-C(7)-C(8) 122.0(4) C(9)-C(8)-C(7) 121.1(3) 
C(8)-C(9)-N(1) 117.8(3) C(8)-C(9)-C(10) 124.8(3) 
N(1)-C(9)-C(10) 117.4(3) C(15)-C(10)-C(11) 116.5(4) 
C(15)-C(10)-C(9) 121.4(3) C(11)-C(10)-C(9) 122.1(3) 
C(12)-C(11)-C(10) 121.9(4) C(11)-C(12)-C(13) 121.2(4) 
C(14)-C(13)-C(12) 116.7(4) C(14)-C(13)-C(16) 122.7(4) 
C(12)-C(13)-C(16) 120.6(4) C(13)-C(14)-C(15) 123.1(4) 
C(14)-C(15)-C(10) 120.5(4) C(6A)-O(2A)-C(17A) 116.0(3) 
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C(1A)-N(1A)-C(9A) 125.8(3) O(1A)-C(1A)-N(1A) 120.5(3) 
O(1A)-C(1A)-C(2A) 122.8(3) N(1A)-C(1A)-C(2A) 116.6(3) 
C(7A)-C(2A)-C(3A) 120.9(3) C(7A)-C(2A)-C(1A) 118.9(3) 
C(3A)-C(2A)-C(1A) 120.2(3) C(4A)-C(3A)-C(2A) 119.3(4) 
C(3A)-C(4A)-C(5A) 122.0(4) C(6A)-C(5A)-C(4A) 119.5(4) 
O(2A)-C(6A)-C(5A) 125.5(4) O(2A)-C(6A)-C(7A) 114.0(3) 
C(5A)-C(6A)-C(7A) 120.6(3) C(2A)-C(7A)-C(6A) 117.8(3) 
C(2A)-C(7A)-C(8A) 119.6(3) C(6A)-C(7A)-C(8A) 122.6(3) 
C(9A)-C(8A)-C(7A) 121.8(3) C(8A)-C(9A)-N(1A) 117.4(3) 
C(8A)-C(9A)-C(10A) 125.0(3) N(1A)-C(9A)-C(10A) 117.6(3) 
C(15A)-C(10A)-C(11A) 116.5(3) C(15A)-C(10A)-C(9A) 122.9(3) 
C(11A)-C(10A)-C(9A) 120.6(4) C(12A)-C(11A)-C(10A) 121.5(4) 
C(13A)-C(12A)-C(11A) 122.1(4) C(12A)-C(13A)-C(14A) 116.4(4) 
C(12A)-C(13A)-C(16A) 121.8(4) C(14A)-C(13A)-C(16A) 121.8(4) 





Table 10. Anisotropic displacement parameters (Å2  103) for 15b. The anisotropic displacement factor 
exponent takes the form: -2 gpi2 [ h2 a*2 U11 + ... + 2 h k a* b* U 
 Atom  U11  U22  U33  U23  U13  U12 
O(1) 43(2) 49(2) 58(2) 2(1) 12(1) 3(1) 
O(2) 82(2) 59(2) 93(3) 16(2) 30(2) 29(2) 
N(1) 39(2) 35(2) 49(2) 6(2) 4(2) 2(1) 
C(1) 44(2) 41(2) 52(3) -5(2) 10(2) -8(2) 
C(2) 42(2) 39(2) 47(3) -4(2) 3(2) -1(2) 
C(3) 61(2) 44(2) 50(3) 5(2) 8(2) 0(2) 
C(4) 80(3) 53(3) 62(4) 5(2) 19(3) 3(2) 
C(5) 92(3) 56(3) 65(4) 12(2) 17(3) 20(2) 
C(6) 70(3) 48(2) 67(4) 0(2) 17(3) 9(2) 
C(7) 48(2) 36(2) 55(3) 1(2) 2(2) 3(2) 
C(8) 50(2) 47(2) 62(3) -3(2) 12(2) 5(2) 
C(9) 39(2) 45(2) 48(3) -3(2) 9(2) -1(2) 
C(10) 40(2) 45(2) 59(3) -6(2) 10(2) 2(2) 
C(11) 83(3) 62(3) 62(4) -2(3) 26(3) 15(2) 
C(12) 86(3) 105(4) 68(4) -2(3) 39(3) 19(3) 
C(13) 77(3) 81(3) 64(4) 9(3) 35(3) 6(3) 
C(14) 73(3) 64(3) 80(4) 13(3) 39(3) 8(2) 
C(15) 57(2) 50(2) 80(4) 2(2) 38(2) 2(2) 
C(16) 133(4) 135(5) 112(6) 43(4) 86(4) 29(4) 
C(17) 117(4) 91(4) 102(5) 35(3) 30(4) 69(3) 
O(1A) 43(2) 59(2) 77(2) 20(2) 19(1) 10(1) 
O(2A) 56(2) 73(2) 71(2) 30(2) 10(2) 20(1) 
N(1A) 44(2) 35(2) 51(2) 5(2) 11(2) 4(1) 
C(1A) 45(2) 40(2) 50(3) -3(2) 13(2) -4(2) 
C(2A) 50(2) 35(2) 62(3) 2(2) 19(2) 2(2) 
C(3A) 58(2) 52(2) 55(3) 4(2) 17(2) 4(2) 
C(4A) 70(3) 50(2) 60(3) 11(2) 21(2) -4(2) 
C(5A) 76(3) 48(2) 53(3) 8(2) 16(2) 4(2) 
C(6A) 54(2) 51(2) 63(3) 7(2) 16(2) 7(2) 
C(7A) 48(2) 38(2) 36(3) 0(2) -1(2) 4(2) 
C(8A) 41(2) 48(2) 57(3) 1(2) 9(2) 0(2) 
C(9A) 39(2) 45(2) 32(3) -8(2) 2(2) 3(2) 
C(10A) 41(2) 41(2) 46(3) -2(2) 12(2) 1(2) 
C(11A) 50(2) 63(3) 73(4) 24(2) 11(2) -4(2) 
C(12A) 44(2) 75(3) 74(4) 10(3) 6(2) -9(2) 
C(13A) 57(3) 52(2) 64(3) 9(2) 16(2) -4(2) 
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C(14A) 62(3) 55(2) 53(3) 11(2) 18(2) 9(2) 
C(15A) 47(2) 50(2) 55(3) 5(2) 15(2) 9(2) 
C(16A) 74(3) 87(3) 70(4) 18(3) 20(3) -10(2) 





Table 5. Hydrogen coordinates ( 104) and isotropic displacement parameters (Å2  103) for 15b. 
 Atom  x  y  z  U(eq) 
H(1) 3591 886 1172 51 
H(3) 4032 2478 -1439 63 
H(4) 3119 3585 -2236 78 
H(5) 1558 4050 -1761 86 
H(8) 1157 2389 873 64 
H(11) 1183 1986 2499 81 
H(12) 712 1286 3798 99 
H(14) 2235 -608 3063 83 
H(15) 2695 70 1737 71 
H(16A) 374 -358 4245 175 
H(16B) 1257 144 5076 175 
H(16C) 1618 -660 4636 175 
H(17A) 436 4602 -799 155 
H(17B) -632 4180 -609 155 
H(17C) -210 3964 -1610 155 
H(1A) 5757 651 808 53 
H(3A) 4885 -1053 3123 65 
H(4A) 5844 -2017 4175 71 
H(5A) 7684 -2282 4239 71 
H(8A) 8504 -518 1850 59 
H(11A) 9268 320 1107 75 
H(12A) 10010 1022 -26 79 
H(14A) 7033 1868 -1417 67 
H(15A) 6257 1139 -330 60 
H(16D) 9513 1596 -1935 115 
H(16E) 9586 2374 -1247 115 
H(16F) 8502 2197 -2152 115 
H(17D) 9103 -2716 3453 123 
H(17E) 9449 -2151 4443 123 





Table 6. Dihedral angles [] for 15b. 
Atom1 - Atom2 - Atom3 - Atom4  Dihedral 
C(9) - N(1) - C(1) - O(1) 177.4(3) 
C(9) - N(1) - C(1) - C(2) -2.0(5) 
O(1) - C(1) - C(2) - C(3) 2.2(5) 
N(1) - C(1) - C(2) - C(3) -178.4(3) 
O(1) - C(1) - C(2) - C(7) -176.6(3) 
N(1) - C(1) - C(2) - C(7) 2.8(5) 
C(7) - C(2) - C(3) - C(4) 1.2(6) 
C(1) - C(2) - C(3) - C(4) -177.6(3) 
C(2) - C(3) - C(4) - C(5) -1.5(6) 
C(3) - C(4) - C(5) - C(6) 1.8(7) 
C(4) - C(5) - C(6) - O(2) 179.7(4) 
C(4) - C(5) - C(6) - C(7) -1.6(7) 
C(17) - O(2) - C(6) - C(5) 7.0(6) 
C(17) - O(2) - C(6) - C(7) -171.8(4) 
C(3) - C(2) - C(7) - C(6) -1.0(5) 
C(1) - C(2) - C(7) - C(6) 177.8(3) 
C(3) - C(2) - C(7) - C(8) 179.1(4) 
C(1) - C(2) - C(7) - C(8) -2.2(5) 
C(5) - C(6) - C(7) - C(2) 1.2(6) 
O(2) - C(6) - C(7) - C(2) -179.9(3) 
C(5) - C(6) - C(7) - C(8) -178.9(4) 
O(2) - C(6) - C(7) - C(8) 0.0(6) 
C(2) - C(7) - C(8) - C(9) 0.5(6) 
C(6) - C(7) - C(8) - C(9) -179.4(4) 
C(7) - C(8) - C(9) - N(1) 0.4(5) 
C(7) - C(8) - C(9) - C(10) -178.8(4) 
C(1) - N(1) - C(9) - C(8) 0.4(5) 
C(1) - N(1) - C(9) - C(10) 179.8(3) 
C(8) - C(9) - C(10) - C(15) 154.8(4) 
N(1) - C(9) - C(10) - C(15) -24.5(5) 
C(8) - C(9) - C(10) - C(11) -25.3(6) 
N(1) - C(9) - C(10) - C(11) 155.4(4) 
C(15) - C(10) - C(11) - C(12) 1.1(7) 
C(9) - C(10) - C(11) - C(12) -178.8(4) 
C(10) - C(11) - C(12) - C(13) 0.5(8) 
C(11) - C(12) - C(13) - C(14) -1.6(7) 
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C(11) - C(12) - C(13) - C(16) 178.9(5) 
C(12) - C(13) - C(14) - C(15) 1.0(7) 
C(16) - C(13) - C(14) - C(15) -179.5(5) 
C(13) - C(14) - C(15) - C(10) 0.6(7) 
C(11) - C(10) - C(15) - C(14) -1.7(6) 
C(9) - C(10) - C(15) - C(14) 178.3(4) 
C(9A) - N(1A) - C(1A) - O(1A) 178.8(3) 
C(9A) - N(1A) - C(1A) - C(2A) 0.7(5) 
O(1A) - C(1A) - C(2A) - C(7A) -178.4(3) 
N(1A) - C(1A) - C(2A) - C(7A) -0.4(5) 
O(1A) - C(1A) - C(2A) - C(3A) 1.4(6) 
N(1A) - C(1A) - C(2A) - C(3A) 179.5(3) 
C(7A) - C(2A) - C(3A) - C(4A) -0.7(6) 
C(1A) - C(2A) - C(3A) - C(4A) 179.4(4) 
C(2A) - C(3A) - C(4A) - C(5A) 0.7(6) 
C(3A) - C(4A) - C(5A) - C(6A) -0.9(6) 
C(17A) - O(2A) - C(6A) - C(5A) 3.8(6) 
C(17A) - O(2A) - C(6A) - C(7A) -175.9(4) 
C(4A) - C(5A) - C(6A) - O(2A) -178.7(4) 
C(4A) - C(5A) - C(6A) - C(7A) 1.0(6) 
C(3A) - C(2A) - C(7A) - C(6A) 0.9(6) 
C(1A) - C(2A) - C(7A) - C(6A) -179.3(4) 
C(3A) - C(2A) - C(7A) - C(8A) -180.0(4) 
C(1A) - C(2A) - C(7A) - C(8A) -0.1(5) 
O(2A) - C(6A) - C(7A) - C(2A) 178.7(3) 
C(5A) - C(6A) - C(7A) - C(2A) -1.1(6) 
O(2A) - C(6A) - C(7A) - C(8A) -0.4(6) 
C(5A) - C(6A) - C(7A) - C(8A) 179.8(4) 
C(2A) - C(7A) - C(8A) - C(9A) 0.3(6) 
C(6A) - C(7A) - C(8A) - C(9A) 179.4(4) 
C(7A) - C(8A) - C(9A) - N(1A) 0.0(5) 
C(7A) - C(8A) - C(9A) - C(10A) 179.7(3) 
C(1A) - N(1A) - C(9A) - C(8A) -0.6(5) 
C(1A) - N(1A) - C(9A) - C(10A) 179.8(3) 
C(8A) - C(9A) - C(10A) - C(15A) 168.2(4) 
N(1A) - C(9A) - C(10A) - C(15A) -12.2(5) 
C(8A) - C(9A) - C(10A) - C(11A) -10.0(6) 
N(1A) - C(9A) - C(10A) - C(11A) 169.7(3) 
C(15A) - C(10A) - C(11A) - C(12A) -1.4(6) 
65 
 
C(9A) - C(10A) - C(11A) - C(12A) 176.9(4) 
C(10A) - C(11A) - C(12A) - C(13A) 1.2(7) 
C(11A) - C(12A) - C(13A) - C(14A) 0.1(7) 
C(11A) - C(12A) - C(13A) - C(16A) -177.7(4) 
C(12A) - C(13A) - C(14A) - C(15A) -1.3(6) 
C(16A) - C(13A) - C(14A) - C(15A) 176.5(4) 
C(13A) - C(14A) - C(15A) - C(10A) 1.2(6) 
C(11A) - C(10A) - C(15A) - C(14A) 0.2(6) 















Section H: Details of the diffraction data and refinement of the structures of complexes 
of selected isoquinolin-1-ones with tankyrase-2. 
Compound 11a 11b 11c 11d 12a 12f 
PDB code 4UVL 4UVP 4UVS 4UVT 4UVZ 4UVO 
Data       












Wavelength (Å) 1.07227 1.07227 0.93340 1.07227 1.07227 0.87260 
Space group C2221 C2221 C2221 C2221 C2221 C2221 
Cell dimensions       




































I / σI 15.50 (2.85) 16.29 (2.19) 14.48 (2.60) 18.62 (3.37) 20.38 (2.78) 17.10 (2.53) 
Completeness 
(%) 
100 (100) 98.4 (85.8) 99.7 (99.9) 99.3 (98.9) 98.4 (97.2) 99.8 (99.9) 
Redundancy 7.2 (7.3) 3.5 (2.7) 3.7 (3.7) 7.2 (7.4) 7.3 (7.4) 5.6 (5.6) 
Refinement       












B-factors       
Protein 26.6065 21.283 19.9235 26.6735 19.3375 21.6805 
Inhibitor 32.4065 19.976 18.473 30.7105 14.0475 26.6415 
R.m.s.d.       
Bond lengths 
(Å) 
0.014 0.015 0.013 0.013 0.014 0.015 
Bond angles () 1.389 1.491 1.305 1.370 1.431 1.441 
Ramachandran 
plot (%) 
      
Favoured 
regions 
98.53 99.27 98.78 98.78 99.02 99.27 
Additionally 
allowed regions 
- 0.57 0.28 0.85 1.13 1.13 
Compound 12m 13h 13n 14f 15e 17 
PDB code 4UVN 4UVV 4UVU 4UVX 4UVY 4UVW 
Data       












Wavelength (Å) 0.93340 0.976250 0.976250 0.976250 0.92000 0.87260 







Cell dimensions  91.23  97.72  117.81 
 
    




































I / σI 12.85 (2.27) 18.59 (2.45) 12.54 (2.38) 13.60 (2.27) 12.59 (2.07) 17.42 (2.87) 
Completeness 
(%) 
97.1 (99.3) 99.9 (100) 
 
99.9 (100) 99.9 (100) 99.9 (99.9) 99.9 (100) 
Redundancy 3.8 (3.7) 6.7 (6.7) 6.6 (6.6) 6.6 (6.6) 6.7 (6.9) 7.4 (7.5) 
Refinement       












B-factors       
Protein 20.947 34.8 35.2 36.6 25.6 38.0 
Inhibitor 16.717 27.9 37.0 31.8 33.8 32.2 
R.m.s.d.       
Bond lengths 
(Å) 
0.013 0.011 0.009 0.011 0.009 0.012 
Bond angles () 1.354 1.4 1.4 1.4 1.2 1.5 
Ramachandran 
plot (%) 
      
Favoured 
regions 
99.02 99.27 98.29 98.53 98.80 98.04 
Additionally 
allowed regions 
0.85 0.73 1.71 1.47 1.20 1.96 
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